Citation: Janine E. Deakin, Renae Domaschenz, Pek Siew Lim, Tariq Ezaz, Sudha Rao. Comparative epigenomics: an emerging field with breakthrough potential to understand evolution of epigenetic regulation[J]. AIMS Genetics, 2014, 1(1): 34-54. doi: 10.3934/genet.2014.1.34
[1] | Maghnia Hamou Maamar, Matthias Ehrhardt, Louiza Tabharit . A nonstandard finite difference scheme for a time-fractional model of Zika virus transmission. Mathematical Biosciences and Engineering, 2024, 21(1): 924-962. doi: 10.3934/mbe.2024039 |
[2] | Luis Ponce, Ryo Kinoshita, Hiroshi Nishiura . Exploring the human-animal interface of Ebola virus disease outbreaks. Mathematical Biosciences and Engineering, 2019, 16(4): 3130-3143. doi: 10.3934/mbe.2019155 |
[3] | Rocio Caja Rivera, Shakir Bilal, Edwin Michael . The relation between host competence and vector-feeding preference in a multi-host model: Chagas and Cutaneous Leishmaniasis. Mathematical Biosciences and Engineering, 2020, 17(5): 5561-5583. doi: 10.3934/mbe.2020299 |
[4] | Chayu Yang, Jin Wang . A mathematical model for the novel coronavirus epidemic in Wuhan, China. Mathematical Biosciences and Engineering, 2020, 17(3): 2708-2724. doi: 10.3934/mbe.2020148 |
[5] | Fangyuan Chen, Rong Yuan . Reconsideration of the plague transmission in perspective of multi-host zoonotic disease model with interspecific interaction. Mathematical Biosciences and Engineering, 2020, 17(5): 4422-4442. doi: 10.3934/mbe.2020244 |
[6] | Ryan Covington, Samuel Patton, Elliott Walker, Kazuo Yamazaki . Improved uniform persistence for partially diffusive models of infectious diseases: cases of avian influenza and Ebola virus disease. Mathematical Biosciences and Engineering, 2023, 20(11): 19686-19709. doi: 10.3934/mbe.2023872 |
[7] | Narges Montazeri Shahtori, Tanvir Ferdousi, Caterina Scoglio, Faryad Darabi Sahneh . Quantifying the impact of early-stage contact tracing on controlling Ebola diffusion. Mathematical Biosciences and Engineering, 2018, 15(5): 1165-1180. doi: 10.3934/mbe.2018053 |
[8] | Rama Seck, Diène Ngom, Benjamin Ivorra, Ángel M. Ramos . An optimal control model to design strategies for reducing the spread of the Ebola virus disease. Mathematical Biosciences and Engineering, 2022, 19(2): 1746-1774. doi: 10.3934/mbe.2022082 |
[9] | Zongmin Yue, Fauzi Mohamed Yusof, Sabarina Shafie . Transmission dynamics of Zika virus incorporating harvesting. Mathematical Biosciences and Engineering, 2020, 17(5): 6181-6202. doi: 10.3934/mbe.2020327 |
[10] | Lan Zou, Jing Chen, Shigui Ruan . Modeling and analyzing the transmission dynamics of visceral leishmaniasis. Mathematical Biosciences and Engineering, 2017, 14(5&6): 1585-1604. doi: 10.3934/mbe.2017082 |
Since 1976, about 25 outbreaks of EVD have been declared including the latest one in Western Africa (2014-2015) which was the most devastating one among human populations [18,56]. There are five known Ebola virus strains: ZEBOV, SEBOV, ICEBOV, BDBV, REBOV [18]. Of these, the first four have highly threatened both human and nonhuman primates, causing viral hemorrhagic fever with case fatality rates of up to 90% [18,50]. For instance, the most recent and deadliest Ebola outbreak in Western Africa was caused by the ZEBOV virus strain.
No approved treatments and homologated vaccines are currently available. However, dedicated research efforts have led to the first therapeutic trial with ZMapp [28]. Furthermore, the VSV-ZEBOV vaccine has been found and is still in its third experimental phase [28]. These two remarkable efforts have helped to curtain the recent Western Africa outbreak, even though the latter effort was less decisive (due to its late trial at the end of the West African outbreak) than the former.
Other control efforts (including rehydration, isolation, education of populations at risk, avoidance of consumption of bush meat, practicing of safe burials) have been implemented to stop past Ebola outbreaks. In addition to the threat EVD poses to human health, the negative impact of EVD infection on already threatened animal populations in Africa has come to light and led to a resurgence of efforts to understand the complex life ecology of Ebola virus in nature [26,51]. However, despite considerable efforts, it remains unclear how the EVD is maintained and transmitted in nature, and how the index case (first patient) is infected. Since EVD is a zoonotic-borne disease (transmitted accidentally by direct contact with infected living or dead animals), human epidemics were concomitant with epizootic in great apes [37,38]. Moreover, due to the fact that recent works have provided new evidence that fruit bats might play an important role as a reservoir species of EVD, some intricate and pending questions which are biologically relevant have been raised:
1. Where and how does the index case (first patient) acquire the infection?
2. Do direct transmissions from bats to humans and/or nonhuman primates occur?
3. Which human behaviors expose humans to the risk of contracting EVD from non-human sources?
4. Are fruit bats the only reservoir hosts for Ebola viruses?
5. What are the environmental factors contributing to Ebola virus transmission to human beings and non-human primates from the reservoir species?
6. Can mathematical modeling help to understand and predict the of EVD outbreaks in the future?
This paper focuses on the last question. We address it, with the ultimate aim to answer the other five questions. Before moving to the modeling section, there is a need to support and motivate these questions. Since the 1976 Sudan outbreak where there was evidence that the index case was a worker in a cotton factory with evidence of bats at site, many other index cases (from 1994-2001) showed evident contacts with bats and/or consumption of butchered great apes and/or other wildlife meat. The synoptic Table 1 summarizes the sources for contamination of the first patient during EVD outbreaks and highlights his/her contact with bats, dead or butchered wildlife bush meat. The table also talks to the transmission from bat to human, from non-human primate to human, and it illustrates how human behaviors can drive the contamination of EVD. The issue of fruit bats being reservoir for Ebola viruses is supported by the work [37] which has demonstrated that fruit bats bear Ebola viruses and are not affected by the disease. Furthermore, the first four questions are biologically investigated in [26,37,51] where the known, the probable/suspected and the hypothetical direct transmission mechanisms (routes) of EVD are addressed. Regarding the fifth question, the works in [9,10,46,53,60] highlight the indirect environmental contamination route of EVD.
Year | Country | Species | Starting date | Source of infection |
1976 | DRC | Zaire | September | Unknown. Index case was a mission school teacher. |
1976 | Sudan | Sudan | June | Worker in a cotton factory. |
Evidence of bats at site. | ||||
1977 | DRC | Zaire | June | Unknown (retrospective). |
1979 | Sudan | Sudan | July | Worker in cotton factory. |
Evidence of bats at site. | ||||
1994 | Gabon | Zaire | December | Gold-mining camps. |
Evidence of bats at site. | ||||
1994 | Ivory Coast | Ivory Coast | November | Scientist performing autopsy on a dead wild chimpanzee. |
1995 | Liberia | Ivory Coast | December | Unknown. Refugee from civil war. |
1995 | DRC | Zaire | January | Index case worked in a forest adjoining the city. |
1996 | Gabon | Zaire | January | People involved in the butchering of a dead chimpanzee. |
1996-1997 | Gabon | Zaire | July | Index case was a hunter living in a forest camp. |
2000-2001 | Uganda | Sudan | September | Unknown. |
2001-2002 | Gabon | Zaire | October | Contact with dead or butchered apes or other wildlife. |
2001-2002 | DRC | Zaire | October | Contact with dead or butchered apes or other wildlife. |
2002-2003 | DRC | Zaire | December | Contact with dead or butchered apes or other wildlife. |
2003 | DRC | Zaire | November | Contact with dead or butchered apes or other wildlife. |
2004 | Sudan | Sudan | May | Unknown. |
2005 | DRC | Zaire | April | unknown. |
2007 | DRC | Zaire | December | Contact with dead or butchered apes or other wildlife. |
2007 | Uganda | Bundibugyo | December | Unknown. |
2008 | DRC | Zaire | December | Index case was a village chief and a hunter. |
2012 | Uganda | Bundibugyo | June | Index case was a secondary school teacher in Ibanda district. |
2012 | DRC | Zaire | June | Index case was a hunter living in a forest camp. |
2013-2015 | Guinea | Zaire | December | Contact with bats or fruits contaminated by bat droppings. |
2014-2015 | Liberia | Zaire | April | Index case was transported from Guinea. |
2014-2015 | Sierra Leone | Zaire | April | A traditional healer, treating Ebola patients from Guinea. |
2014 | DRC | Zaire | August | Pregnant women who butchered a bush animal. |
The complexity of the questions raised above is captured in [26,51] for the EVD mechanisms of transmission in a complex Ebola virus life ecology as depicted in Fig. 1 of the disease transmission diagram. This will be reflected in the construction of our model by: (a) Taking into account the well known, the probable/suspected, the hypothetical and the environmental transmission pathways; (b) Involving the interplay between the epizootic phase (during which the disease circulates periodically amongst non-human primate populations and decimates them), the enzootic phase (during which the disease always remains in fruit bat populations) and the epidemic phase (during which the EVD threatens and decimates human populations) of the disease under consideration.
The complexity of the Ebola virus life ecology is clear from the biological studies carried out in [26,51] (see also Ebola virus ecology and transmission therein). From the mathematical point of view, the complexity and challenges we are confronted with and have addressed range from the modeling of the forces of infection, the computation of the reproduction number (see Eq. (8) and Remark1), the computation of the endemic equilibrium, to the use of less standard tools (e.g. decomposition techniques [54]) to investigate the dynamics of EVD.
Note that the recent and former EVD outbreaks have highlighted the importance of human behavior in the transmission process [11,21,41]. For instance, there were evidence of behavioral reaction and self-protection measures: people were scared, they panicked and left care centers, etc... As this important feature calls for a different modeling approach based on "Behavioral Epidemiology" developed in [41], we are busy investigating it in another work, where self-protection measures driven by human behavior is incorporated.
The rest of the paper is organized as follows. In Section 2 we derive the model. The mathematical analysis starts in Section 3 with the basic properties of the model, followed by the computation of the reproduction number
To avoid confusion, bat will not be called "animal". The term animal is reserved for any non-human primate and/or any other wild animal that may be responsible for the transmission of EVD. Note that our model formulation is focused essentially on non-human primates (great apes) as animal species.
Motivated by the biological papers [25,26,37,51] regarding the transmission mechanisms and the recent mathematical works [9,53], our model is based on the zoonotic-borne disease setting and takes into account both direct and indirect transmission routes. We distinguish three host populations: humans and animals as end hosts and fruit bats as intermediate reservoir hosts [5,32,37,45,47]. Since the model incorporates the indirect environmental transmission, we add the dynamics of the concentration of free living Ebola viruses in the environment [53,56,60]. The latter compartment should not be considered as an epidemiological class; it is regarded as a pool of Ebola viruses. This pool is supplied by infected humans, infected animals and infected fruit bats with:
(ⅰ) The presence of carcasses of infected and dead animals in the forest on which some animals can feed [56].
(ⅱ) The manipulation of infected fruit bats and animals hunted by humans for food.
(ⅲ) The contaminated fruits harvested for food by humans and primates in the forest [25,26,37].
(ⅳ) The contaminated syringes re-used in health care centers [50,55,58].
(ⅴ) The bed linen contaminated by infected human's stool, urine, vomits or sweat in health care centers or in family homes of infected individuals [50,55].
(ⅵ) The bush fruits contaminated by bats droppings [38].
As mentioned earlier, the variables include the human, the animal, the bat (reservoir of Ebola viruses) populations and the concentration of free living Ebola viruses in the environment. More precisely, at time
The model derivation is based on the following main assumptions:
The works in [26,51] amongst others on the complex Ebola virus life ecology lead to the dynamics flowchart in Fig. 1 which in turn gives the following system of nonlinear ordinary differential equations:
$ \dfrac{dS_h}{dt} = \Lambda_h - (\lambda_h+ \mu_h)S_h, $ | (1a) |
$ \dfrac{dE_h}{dt} = \lambda_hS_h - \left(\mu_h + \omega\right)E_h, $ | (1b) |
$ \dfrac{dI_h}{dt} = \omega E_h - \left( \mu_h+\gamma \right)I_h, $ | (1c) |
$ \dfrac{dR_h}{dt} = \gamma(1-f)I_h - \mu_hR_h, $ | (1d) |
$ \dfrac{dV}{dt} = \alpha_h I_h + \alpha_a I_a + \alpha_b I_b - \mu_v V, $ | (1e) |
$ \dfrac{dS_a}{dt} = \Lambda_a - (\lambda_a+ \mu_a) S_a, $ | (1f) |
$ \dfrac{dI_a}{dt} = \lambda_aS_a - (\mu_a +\delta_a ) I_a, $ | (1g) |
$ \dfrac{dS_b}{dt} = \Lambda_b - (\lambda_b + \mu_b)S_b, $ | (1h) |
$ \dfrac{dI_b}{dt} = \lambda_bS_b -\mu_b I_b. $ | (1i) |
The force of infection acting on humans is,
$ \lambda_h=\dfrac{\beta_{hh}\left(I_h+\xi_h\nu_h\gamma f I_h + \theta_h\gamma(1-f) I_h\right)}{N_h} + \dfrac{\beta_{ha}\left(1+\xi_a\nu_a\delta_a\right)I_a}{N_h}+ \dfrac{\beta_{hb}I_b}{N_h} + \dfrac{\beta_{hv}V}{K+V}. $ | (2) |
It is the sum of the contributions below:
● The human-to-human force of infection
$ \lambda_{hh} = \dfrac{\beta_{hh}}{N_h}\left(1+\xi_h\nu_h\gamma f + \theta_h\gamma(1-f)\right)I_h, $ |
which gathers the three contamination processes by:
-infected, i.e.
-Ebola-deceased, i.e.
-clinically recovered individuals i.e.
● The animal-to-human force of infection
$ \lambda_{ha} = \dfrac{\beta_{ha}(1 + \xi_a\nu_a\delta_a)I_a}{N_h}, \;\;\;\;\text{where} \;\;\;\; \xi_a = \dfrac{1}{\tau_a}. $ |
● The bat-to-human force of infection
$ \lambda_{hb}= \dfrac{\beta_{hb}I_b}{N_b}. $ |
● The environment-to-human force of infection
$ \lambda_{hv}= \dfrac{\beta_{hv}V}{K+V}. $ |
Similarly, the force of infection within the animal population
$ \lambda_a= \dfrac{\beta_{aa} (1 + \xi_a\nu_a\delta_a)I_a}{N_a} + \dfrac{\beta_{ab}I_b}{N_a} + \dfrac{\beta_{av}V}{K+V}, $ | (3) |
involves the following three contributions:
● The animal-to-animal force of infection
$ \lambda_{aa}= \dfrac{\beta_{aa} (1+\xi_a\nu_a\delta_a)I_a}{N_a}; $ |
● The bat-to-animal force of infection
$ \lambda_{ab}= \dfrac{\beta_{ab}I_b}{N_a}. $ |
● The environment-to-animal force of infection
$ \lambda_{av}= \dfrac{\beta_{av}V}{K+V}. $ |
Finally, the force of infection in bat's population is modeled by
$ \lambda_b = \beta_{bb}I_b + \dfrac{\beta_{bv}V}{K+V} $ | (4) |
and consists of two contributions from:
-Within bat adequate contacts
$ \lambda_{bb} = \beta_{bb}I_b. $ |
-The contact with the environment
$ \lambda_{bv} = \dfrac{\beta_{bv}V}{K+V}. $ |
Note that we have considered the infection through contact with environmental free Ebola viruses. As it is the case for most models involving free-living pathogens in the environment [3,4,8,12,17,49,53,59], the environmental-related forces of infection,
Finally, the last equation of system (1) describes the dynamics of Ebola viruses with shedding from humans, animals and bats. The parameters used for system (1) and their biological interpretations are giving in Table 2. For notational simplifications let,
Symbols | Biological interpretations |
|
Recruitment rate of susceptible humans, animals and bats, respectively. |
|
Natural mortality rate of humans, animals and bats, respectively. |
|
Virulence of Ebola virus in the corpse of the dead humans. |
|
Mean duration of time that elapse after death before a human cadaver is completely buried. |
|
Modification parameter of infectiousness due to dead human individuals. |
|
Mean duration of time that elapse after death before an animal's cadaver is completely cleared out. |
|
Modification parameter of infectiousness due to dead animals individuals. |
|
Virulence of Ebola virus in the corpse of dead animals. |
|
Incubation rate of human individuals. |
|
Removal rate from infectious compartment due to either to disease induced death, or by recovery. |
|
Death rate of infected animals. |
|
Shedding rates of Ebola virus in the environment by humans, animals and bats, respectively. |
|
Mean duration of time that elapse before the complete clearance of Ebola virus in humans. |
|
Modification parameter of contact rate of recovered humans (sexual activity of recovered). |
in the semen/breast milk of a recovered man/woman. | |
|
Proortion of removed human individuals who die due EVD (i.e. case fatality rate). |
|
Virus 50 % infectious dose, sufficient to cause EVD. |
|
Contact rate between susceptible humans and infected humans. |
|
Contact rate between susceptible humans and bats. |
|
Contact rate between susceptible humans and Ebola viruses. |
|
Contact rate between susceptible humans and infected animals. |
|
Contact rate between susceptible bats and infectious bats. |
|
Contact rate between susceptible animals and infectious bats. |
|
Contact rate between susceptible bats and and Ebola viruses. |
|
Contact rate between susceptible and infected animals. |
|
Contact rate between susceptible animals and Ebola viruses. |
$ \Phi_h = 1+\xi_h\nu_h\gamma f + \theta_h\gamma(1-f) \;\;\;\; \text{and} \;\;\;\; \Phi_a = 1+\xi_a\nu_a\delta_a. $ |
With this notation it is easy to check that system (1) interconnects the following sub-models:
● The human population sub-model
$ \left\{dShdt=Λh−βhhΦhShIhNh−βhaΦaShIaNh−βhbShIbNh−βhvShVK+V−μhSh,dEhdt=βhhΦhShIhNh+βhaΦaShIaNh+βhbShIbNh+βhvShVK+V−(μh+ω)Eh,dIhdt=ωEh−(μh+γ)Ih,dRhdt=γ(1−f)Ih−μhRh.\right. $ | (5) |
● The animal population sub-model
$ \left\{dSadt=Λa−βaaΦaSaIaNa−βabSaIbNa−βavSaVK+V−μaSa,dIadt=βaaΦaSaIaNa+βabSaIbNa+βavSaVK+V−(μa+δa)Ia.\right. $ | (6) |
● The bat population sub-model
$ \left\{dSbdt=Λb−βbbSbIb−βbvSbVK+V−μbSb,dIbdt=βbbSbIb+βbvSbVK+V−μbIb.\right. $ | (7) |
It should be emphasized that not much is known about the bat-to-bat EVD transmission. However, knowing that fruit bats settle or congregate for rest or sleep (they live in colony), it is acceptable to assume that direct bat-to-bat contact is the main route of transmission and can be modeled by mass action incidence.
● The evolution of free-living Ebola viruses in the environment which is modeled by Eq. (1e).
The model presented her is a new in many respects. It extends the existing works [1,9,16,24,35,36,44,53] in the sense that it considers the three phases of disease: the epizootic cycle in animals, the enzootic phase in fruit bats and the epidemic phase in humans. In particular, the novelty of our model is clear from the most recent work [9], where direct human-to-human transmission was considered and all other sources (e.g. consumption of bush meat, manipulation of fruit bats, indirect environmental contamination) were encompassed in a constant recruitment of Ebola viruses in the environment. The model developed here enriches the latter by modeling this recruitment through consideration of the complex Ebola virus life ecology, where animals and bats are explicitly involved in the EVD transmission cycle. It is therefore understandable why throughout this paper, we refer to system (1) as the full model.
For the EVD transmission model (1) to be epidemiological meaningful, it is important to prove that all state variables are non-negative at all time. That is, solutions of the system (1) with non-negative initial data will remain non-negative for all time
Theorem 3.1. Let the initial data
Furthermore, if we set
$N_h(0)\leq \dfrac{\Lambda_h}{\mu_h},\;\; N_a(0)\leq \dfrac{\Lambda_a}{\mu_a}, \;\;N_b(0)\leq \dfrac{\Lambda_b}{\mu_b} , \;\;V(0)\leq \dfrac{\Lambda_v}{\mu_v}, $ |
we have
$ N_h(t)\leq \dfrac{\Lambda_h}{\mu_h}, \;\; N_a(t)\leq \dfrac{\Lambda_a}{\mu_a},\;\; N_b(t)\leq \dfrac{\Lambda_b}{\mu_b} ,\;\; V(t)\leq \dfrac{\Lambda_v}{\mu_v}, \; \forall t\geq 0. $ |
Proof. Suppose
$\dfrac{d}{dt}\left\{S_h(t)\rho(t)\right\} = \Lambda_h\rho(t), $ |
where
$ S_h(t)\rho(t) - S_h(0) = \int^{t}_0 \Lambda_h \rho(t)dt, $ |
so that the division of both side by
$ S_h(t) = \left[S_h(0) + \int^{t}_0 \Lambda_h \rho(t)dt \right]\times \rho(t)^{-1} >0. $ |
The same arguments can be used to prove that
Furthermore,
Finally, using the fact that
Combining Theorem 3.1 with the trivial existence and uniqueness of a local solution for the model (1), we have established the following theorem which ensures the mathematical and biological well-posedness of system (1) (see [9], Theorem 3.3).
Theorem 3.2. The dynamics of model (1) is a dynamical system in the biological feasible compact set
$ \Gamma = \left\{(S_h, E_h, I_h, R_h, S_a, I_a, S_b, I_b, V) \in \mathbb R^9_+: N_h\leq \frac{\Lambda_h}{\mu_h}, N_a\leq \frac{\Lambda_a}{\mu_a}, N_b\leq \frac{\Lambda_b}{\mu_b}, V\leq \frac{\Lambda_v}{\mu_v} \right\} $ |
The disease free equilibrium (DFE) of the model is obviously
$P_0 = \left( S^0_h, 0, 0, 0, S^0_a, 0, S^0_b, 0, 0\right),\;\; \text{where} \;\; S^0_h = \dfrac{\Lambda_h}{\mu_h},\;\; S^0_a = \dfrac{\Lambda_a}{\mu_a},\;\; S^0_b = \dfrac{\Lambda_b}{\mu_b}.$ |
To compute the basic reproduction number of the model, we use the standard method of the next generation matrix developed in [2,8,19,20]. We separate the infected states
$ \mathcal F= \left(λhSh00λaSaλbSb0\right) \;\; \text{and}\;\; \mathcal W = \left((μh+ω)Eh−ωEh+(μh+γ)Ih−γ(1−f)Ih+μhRh(μa+δa)IaμbIb−αhIh−αaIa−αbIb+μvV\right). $ |
The Jacobian matrices
$ F= \left(0βhhΦh0βhaΦaβhbβhvΛhμhK000000000000000βaaΦaβabβavΛaμaK0000βbbΛbμbβbvΛbμbK000000\right) $ |
and
$ W= \left((μh+ω)00000−ω(μh+γ)00000−γ(1−f)μh000000μa+δa000000μb00−αh0−αa−αbμv\right), \text{respectively}.$ |
$ FW^{-1} = (Rhhv0Rhhv200Rahv0Rbhv0βhvΛhKμhμv000000000000Rhav0βavαhΛaKμaμv(μh+γ)0Raav0Rbav0βavΛaKμaμvRhbv0βbvαhωKμbμv(μh+γ)0Rabv0Rbbv0βbvΛbKμbμv000000)$ |
and
$ Rhhv0=βhhΦhω(μh+ω)(μh+γ)+αhβhvΛhωKμhμv(μh+ω)(μh+γ),Rbav0=βavΛaαbKμaμbμv+βabμb,Rahv0=βhaΦaμa+δa+βhvαaΛhKμhμv(μa+δa),Rbhv0=βhbμb+βhvαbΛhKμhμbμv,Raav0=βaaΦaμa+δa+βavΛaαaKμaμv(μa+δa),Rabv0=βbvΛbαaKμbμv(μa+δa),Rhav0=βavαhΛaωKμaμv(μh+ω)(μh+γ),Rhbv0=βbvαhΛbωKμbμv(μh+ω)(μh+γ),Rbbv0=βbbΛbμ2b+βbvΛbαbKμ2bμv,Rhhv20=βhhΦhμh+γ+βhvαhΛhKμh(μh+γ). $ |
Since zero is an eigenvalue for
$ \mathcal G = \left(Rhhv0Rahv0Rbhv0Rhav0Raav0Rbav0Rhbv0Rabv0Rbbv0\right), $ | (8) |
Therefore,
$\mathcal R_0= \rho{(\mathcal G)}, $ |
where for a square matrix
Based on some of the realistic assumptions stated in subsection 2.2, the remark below gives the explicit formula of the basic reproduction number
Remark 1. In some cases, the explicit formula for
1. In the sub-model with only human population dynamics and environmental transmission [53], the basic reproduction number denoted by
$ \mathcal R_{0, hv} = \mathcal R^{hhv}_0 = \dfrac{\beta_{hh}\Phi_h\omega}{(\mu_h+\omega)(\mu_h+\gamma)} + \dfrac{\alpha_h\beta_{hv}\Lambda_h\omega}{K\mu_h\mu_v(\mu_h+\omega)(\mu_h+\gamma)}. $ | (9) |
If in addition, the indirect transmission is neglected (i.e.
$ \mathcal R_{0, h} = \dfrac{\beta_{hh}\Phi_h\omega}{(\mu_h+\omega)(\mu_h+\gamma)}. $ | (10) |
We emphasize that the basic reproduction number giving by (10) is suitable for comparison with the basic reproduction numbers for some existing EDV models. For instance, looking at the expression
(ⅰ) The contribution from infected human individuals, i.e.
(ⅱ) The contribution from the clinically recovered individuals, i.e.
(ⅲ) The contribution from Ebola-deceased individuals, i.e.
With the above decomposition of
2. In the sub-model without animal's population dynamics, the basic reproduction number denoted by
$ \mathcal R_{0, hbv}= \dfrac{\mathcal R^{hhv}_0+\mathcal R^{bbv}_0+ \sqrt{\left(\mathcal R^{hhv}_0-\mathcal R^{bbv}_0\right)^2+4\mathcal R^{hbv}_0\mathcal R^{bhv}_0}}{2}. $ | (11) |
3. In the sub-model without bat's population dynamics, the basic reproduction number denoted by
$ \mathcal R_{0, hav}=\dfrac{\mathcal R^{hhv}_0+\mathcal R^{aav}_0+ \sqrt{\left(\mathcal R^{hhv}_0-\mathcal R^{aav}_0\right)^2+4\mathcal R^{hav}_0\mathcal R^{ahv}_0}}{2}. $ | (12) |
4. Suppose
$ \mathcal R_0 = \max\left\{\mathcal R_{0, b} \; ;\; \dfrac{\mathcal R^{hhv}_0+\mathcal R^{aav}_0 + \sqrt{\left(\mathcal R^{hhv}_0-\mathcal R^{aav}_0\right)^2+4\mathcal R^{hav}_0\mathcal R^{bhv}_0}}{2}\right\}. $ | (13) |
5. If
$ \mathcal R_0 = \max\left\{ \mathcal R_{0, hv}\; ; \; \mathcal R_{0, a} \; ;\; \mathcal R_{0, b} \right\} $ | (14) |
where
$ \mathcal R_{0, a} = \dfrac{\beta_{aa}\Phi_a}{\delta_a +\mu_a} \;, \; \mathcal R_{0, b} = \dfrac{\beta_{bb}\Lambda_b}{\mu^2_b} $ | (15) |
are the intra-specific basic reproduction numbers of the animal's population and bat's population without the environmental transmission, respectively and
Using Theorem 2 in [20], the following result is established:
Lemma 3.3. The DFE of system (1) is LAS whenever
The epidemiological implication of Lemma 3.3 is that EVD can be eliminated from the community when
Theorem 3.4. The DFE
Proof. Let
$ \left\{dxdt=(F−W)x−f(x,y),dydt=g(x,y), \right. $ | (16) |
where
$f(x,y)=((Nh−Sh)[βhhΦhIh+βhaΦaIaNh+βhbIb]+βhvV(ΛhμhK−ShK+V)00(Na−Sa)[βaaΦaIa+βabIbNa]+βavV(ΛaμaK−SaK+V)βbbIb(Λbμb−Sb)+βbvV(ΛbμbK−SbK+V)0),$ |
and
$ g(x, y) = (Λh−λhSh−μhShΛa−λaSa−μaSaΛb−λbSb−μbSb). $ |
It is straightforward that
$ \dfrac{d\widehat{x}}{dt} = \left(F-W\right)\widehat{x}. $ | (17) |
From Theorem 2 in [20], we have
$ \left\{d¯Shdt=Λh−μh¯Sh,d¯Sadt=Λa−μa¯Sa,d¯Sbdt=Λb−μb¯Sb. \right. $ | (18) |
It is straightforward that the linear system (18) has a unique equilibrium given by
Remark 2. To extend this global result in the case when
In this section, we investigate the existence of equilibrium points other than the disease free equilibrium, namely possible boundary equilibrium points and interior equilibria. First of all, let us give some useful remarks.
Assume that an equilibrium is such that
Similarly, if an equilibrium of (1) is such that
Obviously, if an equilibrium of (1) is such that
Conversely, assume the human population is disease free, then the free virus concentration
As a consequence, we have proven the following result:
Lemma 3.5. System (1) has no other boundary equilibrium than the disease-free equilibrium.
This lemma is very important as it excludes the possibility for the full model (1) to exhibit non trivial boundary equilibrium points. This suggests that the full model could have exactly one interior (endemic) equilibrium with the disease being present in all the populations under consideration. This, together with the existence and uniqueness of interior equilibrium for some system (1)-related sub-models [9], motivates the following conjecture that we make.
Conjecture 1. Assume that
The stability of the endemic equilibrium will be shown numerically at a later stage.
Remark 3. Actually, Conjecture 1 could be addressed in a separate work, by reducing the finding of equilibria to a fixed-point problem and apply a suitable fixed-point theorem for a multi-variable and sub-linear function for monotone dynamical systems or for systems of ordinary differential equations which generate an order preserving flow [29,30,48].
In order to investigate the effects of the environmental contamination on the transmission of EVD, it is reasonable to consider the sub-model of system (1) without the environment compartment. Note that, even though the full model (which couples many subsystems) could have two equilibria (namely, the disease free and the interior equilibria), it is not obvious that all its sub-models will exhibit the same property since the coupling can reduce or increase for example the number of equilibrium points. Below is the sub-model involving only human, animal and bat populations, but excluding the environment influence.
Here the environmental transmission is neglected. This assumption reflects the disease transmission cycles in [26,51], where the indirect contamination is not explicitly mentioned. This amounts to getting rid of the last terms in Eqs. (2)-(4) of the forces of infection. The model in this setting reads therefore:
$ \dfrac{dS_h}{dt} = \Lambda_h - \dfrac{\beta_{hh}\Phi_hS_hI_h}{N_h} - \dfrac{\beta_{ha}\Phi_aS_hI_a}{N_h} - \dfrac{\beta_{hb}S_h I_b}{N_h} - \mu_hS_h $ | (19a) |
$ \dfrac{dE_h}{dt} = \dfrac{\beta_{hh}\Phi_hS_hI_h}{N_h} + \dfrac{\beta_{ha}\Phi_aS_hI_a}{N_h} +\dfrac{\beta_{hb}S_h I_b}{N_h} - \left(\mu_h + \omega\right)E_h $ | (19b) |
$ \dfrac{dI_h}{dt} = \omega E_h - \left( \mu_h+\gamma \right)I_h $ | (19c) |
$ \dfrac{dR_h}{dt} = \gamma(1-f)\, I_h - \mu_hR_h $ | (19d) |
$ \dfrac{dS_a}{dt} = \Lambda_a - \dfrac{\beta_{aa}\Phi_a S_a I_a}{N_a} - \dfrac{\beta_{ab} S_a I_b}{N_a} - \mu_a S_a $ | (19e) |
$ \dfrac{dI_a}{dt} = \dfrac{\beta_{aa}\Phi_a S_a I_a}{N_a} + \dfrac{\beta_{ab} S_a I_b}{N_a} - (\mu_a +\delta_a ) I_a $ | (19f) |
$ \dfrac{dS_b}{dt} = \Lambda_b - \beta_{bb} S_b I_b - \mu_bS_b $ | (19g) |
$ \dfrac{dI_b}{dt} = \beta_{bb} S_b I_b - \mu_b I_b $ | (19h) |
The corresponding basic reproduction for this model is easily computed as
$ \mathcal R_{0, hab} = \max\left\{\mathcal R_{0, h}\;, \; \mathcal R_{0, a} \;, \; \mathcal R_{0, b} \right\} $ | (20) |
where,
$ \mathcal R_{0, h} = \dfrac{\beta_{hh}\Phi_h\omega}{(\mu_h+\omega)(\mu_h+\gamma)},\;\; \mathcal R_{0, a}= \dfrac{\beta_{aa}\Phi_a}{\mu_a +\delta_a} \: \: \text{and} \: \: \mathcal R_{0, b} = \dfrac{\beta_{bb}\Lambda_b}{\mu^2_b}. $ | (21) |
Actually,
Remark 4. Note that the non-negative matrix
$ \mathcal R_{0} = \rho{(\mathcal G)} \geq \mathcal R_{0, hab}.$ |
Consequently, the indirect environmental contamination enhances the transmissibility of EVD, and thus it increases the epidemic/endemic level of the disease.
The dynamics of sub-system (19) are confined in the biological feasible compact set subset of
$ \Gamma_{hab} = \left\{(S_h, E_h, I_h, R_h, S_a, I_a, S_b, I_b) \in \mathbb R^5_+ : N_h\leq \dfrac{\Lambda_h}{\mu_h }, \;\; N_a\leq \dfrac{\Lambda_a}{\mu_a }, \: \, N_b\leq \dfrac{\Lambda_b}{\mu_b } \right\}. $ | (22) |
Sub-model (19) is triangular. Indeed the variables (
Theorem 4.1. ([54], Theorem 3.1) Consider the system
$ \left\{dxdt=f(x),x∈Rn,dydt=g(x,y),x∈Rn,y∈Rm,withright−handsideofclassC1,and(x∗,y∗)anequilibriumpoint,i.e.,f(x∗)=0=g(x∗,y∗). \right. $ | (23) |
1.If
2. Moreover, if all the trajectories of system (23) are forward bounded, then
In order to apply Theorem 4.1, we need to study some sub-systems of Eq. (19).
We give here the long run behavior of the sub-model
$ \left\{dSbdt=Λb−βbbSbIb−μbSb,dIbdt=βbbSbIb−μbIb,\right. $ | (24) |
by establishing the global stability of its equilibrium points. Obviously this system (24) has two equilibria; namely, the disease-free equilibrium
$ S^0_b= \dfrac{\Lambda_b}{\mu_b},\;\; I^0_b=0 $ |
and the endemic equilibrium
$ \overline{P}_b = \left(\overline{S}_b, \, \overline{I}_b \right), $ |
which exists whenever
$ \overline{S}_b = \dfrac{\mu_b}{\beta_{bb}},\;\; \overline{I}_b = \dfrac{ \mu_b\left(\mathcal R_{0, b}-1\right)}{\beta_{bb}}. $ | (25) |
Obviously the dynamics of sub-model (24) are confined in the biological feasible compact set
$\Omega_b = \left\{ (S_b, I_b)\in \mathbb R^2_+ : S_b+I_b \leq \dfrac{\Lambda_b}{\mu_b}\right\}.$ |
Looking at model (24) in which the mass action law is applied, it is standard to deduce from the Lyapunov-LaSalle techniques its asymptotic behavior summarized in the result below.
Proposition 1. The following statements hold:
● If
● If
Here, we consider the subsystem (19e)-(19f)
$ \left\{dSadt=Λa−βaaΦaSaIaNa−βabSaIbNa−μaSa,dIadt=βaaΦaSaIaNa+βabSaIbNa−(μa+δa)Ia.\right. $ | (26) |
The dynamics of sub-model (26) are confined in the biological feasible compact set
$\Omega_a = \left\{ (S_a, I_a)\in \mathbb R^2_+ : S_a+I_a \leq \dfrac{\Lambda_a}{\mu_a}\right\}.$ |
Using the global asymptotic stability of equilibria for subsystem (24), the following two subsystems will be considered.
The variables
$ \left\{dSadt=Λa−βaaΦaSaIaNa−μaSa,dIadt=βaaΦaSaIaNa−(μa+δa)Ia.\right. $ | (27) |
Direct calculations show that model (27) has two possible non-negative equilibrium states: the disease-free equilibrium
$ \left\{¯Sa=Λaμa+(μa+δa)(R0,a−1),¯Ia=Λa(R0,a−1)μa+(μa+δa)(R0,a−1).\right. $ |
We have the following proposition:
Proposition 2. The following statements are satisfied.
● If
● When
Proof. The GAS of the disease-free equilibrium
$V_0(S_a, I_a) = \dfrac{1}{2}I^2_a. $ |
The directional derivative of
$˙V0(Sa,Ia)=[βaΦaSa−(μa+δa)Na]I2aNa,=−(μa+δa)[Ia+(R0,a−1)Sa]I2aNa.$ |
Thus,
For the GAS of the endemic equilibrium
$Q(Sa,Ia)=(Sa+Ia)−(¯Sa+¯Ia)−(¯Sa+¯Ia)ln(Sa+Ia¯Sa+¯Ia)+k(Ia−¯Ia−¯IalnIa¯Ia),=Na−¯Na−¯NalnNa¯Na+k(Ia−¯Ia−¯IalnIa¯Ia), $ |
defined in the set
$ \Lambda_a = \mu_a\overline{N}_a -\delta_a\overline{I}_a, (\mu_a+\delta_a) = \dfrac{\beta_{aa}\Phi_a\overline{S}_a}{\overline{N}_a}.$ |
With this in mind and the fact that
$\dfrac{S_a}{S_a+I_a} - \dfrac{\overline{S}_a}{\overline{S}_a+\overline{I}_a} = \dfrac{\overline{I}_a(S_a - \overline{S}_a) - \overline{S}_a(I_a-\overline{I}_a)}{(S_a+I_a)(\overline{S}_a+\overline{I}_a)}, $ |
the directional derivative
$˙Q=−μa(Sa−¯Sa)2Sa+Ia−(μa+δa+kβaaΦa¯Sa¯Sa+¯Ia)(Ia−¯Ia)2Sa+Ia,−(2μa+δa−kβaaΦa¯Ia¯Sa+¯Ia)(Ia−¯Ia)(Sa−¯Sa)Sa+Ia. $ |
Choose the constant
$2\mu_a +\delta_a - \dfrac{k\beta_{aa}\Phi_a\overline{I}_a}{\overline{S}_a+\overline{I}_a} = 0, $ |
or equivalently
$ k= \dfrac{(2\mu_a +\delta_a)\overline{S}_a+\overline{I}_a}{\beta_{aa}\Phi_a\overline{I}_a}. $ |
Thus, the directional derivative of
$\dot Q = - \dfrac{\mu_a(S_a-\overline{S}_a)^2}{S_a+I_a} - \left(\mu_a +\delta_a + \dfrac{k\beta_{aa}\Phi_a\overline{S}_a}{\overline{S}_a+\overline{I}_a}\right) \dfrac{(I_a-\overline{I}_a)^2}{S_a +I_a}, $ |
from which we can see clearly that
Sub-model (26) is considered when the bat population is at endemic state
$ \left\{dSadt=Λa−βaaΦaSaIaNa−βabSa¯IbNa−μaSa,dIadt=βaaΦaSaIaNa+βabSa¯IbNa−(μa+δa)Ia.\right. $ | (28) |
Since
Let
$ \overline{D}_b= \beta_{ab}\overline{I}_b. $ | (29) |
$ \left\{Λa−(βaaΦaˆIa+¯Db)ˆSaˆNa−μaˆSa=0,(βaaΦaˆIa+¯Db)ˆSaˆNa−(μa+δa)ˆIa=0.\right. $ | (30) |
Set
$ \widehat{\lambda}_a =\dfrac{\beta_{aa}\Phi_a \widehat{I}_a + \overline{D}_b}{\widehat{N}_a}. $ | (31) |
Then, from (30) and (31), we have
$ \widehat{S}_a = \dfrac{\Lambda_a}{\mu_a + \widehat{\lambda}_a}, \;\; \widehat{I}_a = \dfrac{\Lambda_a\widehat{\lambda}_a}{\left(\mu_a + \delta_a\right)\left(\mu_a + \widehat{\lambda}_a\right)}, \;\; \widehat{N}_a = \dfrac{\Lambda_a\left(\mu_a + \delta_a + \widehat{\lambda}_a\right)}{\left(\mu_a + \delta_a\right)\left(\mu_a + \widehat{\lambda}_a\right)}. $ | (32) |
Substituting (32) into (31) yields
$ \widehat{\lambda}_a =\dfrac{\beta_{aa}\Phi_a \Lambda_a\widehat{\lambda}_a + \overline{D}_b\left(\mu_a + \delta_a\right)\left(\mu_a + \widehat{\lambda}_a\right)}{\Lambda_a\left(\mu_a + \delta_a + \widehat{\lambda}_a\right)}. $ |
From this latter expression, we derive the quadratic equation
$ \Lambda_a \left(\widehat{\lambda}_a\right)^2 + \left[\Lambda_a\left(\mu_a + \delta_a \right)-\overline{D}_b(\mu_a+\delta_a)-\beta_{aa}\Phi_a \Lambda_a \right] \widehat{\lambda}_a - \mu_a\left(\mu_a + \delta_a \right)\overline{D}_b = 0. $ | (33) |
Denote the discriminant of Eq. (33) by
$ \Delta_a = \left[\Lambda_a\left(\mu_a + \delta_a \right)-\overline{D}_b(\mu_a+\delta_a)-\beta_{aa}\Phi_a \Lambda_a \right]^2 + 4\mu_a\Lambda_a\left(\mu_a+\delta_a\right)\overline{D}_b >0. $ | (34) |
Then, the unique positive root of Eq. (33) is
$ \widehat{\lambda}_a = \dfrac{ \left(\beta_{aa}\Phi_a - \mu_a - \delta_a\right) \Lambda_a + \overline{D}_b(\mu_a+\delta_a)+ \sqrt{\Delta_a}}{2\Lambda_a}. $ | (35) |
Thus, the components of the unique equilibrium point
$ \left\{ˆSa=2Λ2a2μaΛa+(βaaΦa−μa−δa)Λa+¯Db(μa+δa)+√Δa,ˆIa=Λa[(βaaΦa−μa−δa)Λa+¯Db(μa+δa)+√Δa](μa+δa)[2μaΛa+(βaaΦa−μa−δa)Λa+¯Db(μa+δa)+√Δa].\right. $ | (36) |
Proposition 3. The endemic equilibrium
Proof. We first establish the LAS of
$ J(\widehat {E}_a) = (−βaaΦa(ˆIa)2(ˆNa)2−¯DbˆIa(ˆNa)2−μa− βaaΦa(ˆSa)2(ˆNa)2+¯DbˆSa(ˆNa)2βaaΦa(ˆIa)2(ˆNa)2+¯DbˆIa(ˆNa)2βaaΦa(ˆSa)2(ˆNa)2−¯DbˆSa(ˆNa)2−(μa+δa)). $ |
Since
$ trace(J(ˆEa))=βaaΦa(ˆSa−ˆIa)−(δa+2μa)ˆNa−¯DbˆNa,=−[(μa+δa)(1−R0,a)+μa]ˆSa−[βaaΦa+2μa+δa]ˆIa−¯DbˆNa,<0. $ | (37) |
Furthermore, the determinant
$ det(J(ˆEa))=βaaΦa(μa+δa)(ˆIa)2+¯Db(μa+δa)ˆIa−μaβaaΦa(ˆSa)2(ˆNa)2+μa¯DbˆSa+μa(μa+δa)(ˆNa)2(ˆNa)2,=(μa+δa)[βaaΦa(ˆIa)2+μa(ˆIa)2+¯DbˆIa+2μaˆSaˆIa](ˆNa)2+(μa+δa)μaˆSa(1−R0,a)+¯Dbμaδa(ˆNa)2, $ | (38) |
which is positive whenever
Secondly, we prove the global attractiveness of
$ g(S_a, I_a) = \dfrac{1}{I_a}, $ |
defined on the connected region
$\dfrac{\partial(gX_1)}{\partial S_a} + \dfrac{\partial(gX_2)}{\partial I_a} = - \dfrac{\beta_{aa}\Phi_a}{N_a} - \dfrac{\overline{D}_b}{I^2_a} - \dfrac{\mu_a}{I_a} < 0.$ |
Hence, by Dulac's criterion, there is no periodic solution in the interior of
We conclude the series of sub-models by studying the dynamics of the human subpopulation when the other subpopulations (bats and animals) are at their different equilibrium states. The subsystem under investigation is constituted of Eqs. (19a)-(19d) given below.
$ \left\{dShdt=Λh−βhhΦhShIhNh−βhaΦaShIaNh−βhbShIbNh−μhSh,dEhdt=βhhΦhShIhNh+βhaΦaShIaNh+βhbShIbNh−(μh+ω)Eh,dIhdt=ωEh−(μh+γ)Ih,dRhdt=γ(1−f)Ih−μhRh. \right. $ | (39) |
Consider the subsystem (19a)-(19d) dealing with human subpopulation, where the animals and bats subpopulations are at disease-free equilibrium
$ \left\{dShdt=Λh−βhhΦhShIhNh−μhSh,dEhdt=βhhΦhShIhNh−(μh+ω)Eh,dIhdt=ωEh−(μh+γ)Ih,dRhdt=γ(1−f)Ih−μhRh. \right. $ | (40) |
Model (40) is well posed mathematically and biologically in the compact set
$ \Omega_h = \left\{ (S_h, E_h, I_h, R_h)\in \mathbb R^4_+ : N_h= S_h+E_h+I_h+R_h \leq \dfrac{\Lambda_h}{\mu_h}\right\}. $ | (41) |
System (40) has two equilibrium points, namely the disease-free
$P^0_h= \left(\dfrac{\Lambda_h}{\mu_h}, 0, 0, 0\right), $ |
which always exists and the endemic equilibrium point
$\mathcal{R}^0_{0h} = \frac{\beta_{hh}\Phi_h\omega}{\left(\mu_h+\omega\right)\left(\mu_h+\gamma\right)} >1. $ |
Set
$B_h = \left(\mu_h+\omega\right)\left(\mu_h+\gamma\right).$ |
Then the components of
$ ¯Sh=Λh[μh(μh+ω+γ)+γω(1−f)]μh[Bh(R00h−1)+μh(μh+ω+γ)+γω(1−f)],¯Eh=Λh(μh+γ)(R00h−1)Bh(R00h−1)+μh(μh+ω+γ)+γω(1−f),¯Ih=ωΛh(μh+γ)(R00h−1)(μh+γ)[Bh(R00h−1)+μh(μh+ω+γ)+γω(1−f)],¯Rh=γ(1−f)ωΛh(μh+γ)(R00h−1)μh(μh+γ)[Bh(R00h−1)+μh(μh+ω+γ)+γω(1−f)]. $ |
The asymptotic behavior of model (40) is completely described by
Theorem 4.2. The following statements hold true:
(1) The disease-free equilibrium point
(2) The endemic equilibrium point
Proof. The first item is established using the Lyapunov function
$L_h= L_h\left(S_h, E_h, I_h, R_h\right) = \dfrac{\omega}{B_h}E_h + \dfrac{1}{\mu_h+\gamma} I_h.$ |
The Lie derivative of
$\dot{L}_h = \left[\dfrac{\beta_{hh}\Phi_h\omega S_h}{B_hN_h}-1 \right]I_h = - \left[\left(1-\mathcal R_{0, h}\right)S_h + E_h+I_h+R_h \right]\dfrac{I_h}{N_h}.$ |
Clearly
As for the second item of Theorem 4.2, the proof of the global asymptotic stability is quiet long and challenging. We refer the interested reader to [39,61] where the proof is provided using a geometrical approach [40].
Thanks to Theorem 4.1 and combining Proposition 1, Proposition 2 and Proposition 4.2 we are now able state the first main result regarding the asymptotic behavior of the environmental-free model (19).
Theorem 4.3. For system (19), the following statements hold true:
1. If
2. If
The model under consideration in this section is
$ \left\{dShdt=Λh−βhhΦhShIhNh−¯DaShNh−μhSh,dEhdt=βhhΦhShIhNh+¯DaShNh−(μh+ω)Eh,dIhdt=ωEh−(μh+γ)Ih,dRhdt=γ(1−f)Ih−μhRh, \right. $ | (42) |
where the constant
$ \overline{D}_a = \beta_{ha}\Phi_a\overline{I}_a. $ | (43) |
This model is obviously a dynamical system on the biological feasible domain given in (41).
Due to the fact
$ \lambda^{**}_h = \dfrac{\beta_{hh}\Phi_h I^{**}_h + \overline{D}_a}{N^{**}_h}. $ | (44) |
Then
$ \left\{Λh−(λ∗∗h+μh)S∗∗h=0,λ∗∗hS∗∗h−(μh+ω)E∗∗h=0,ωE∗∗h−(μh+γ)I∗∗h=0,γ(1−f)I∗∗h−μhR∗∗h=0. \right. $ | (45) |
From (45), we have
$ \left\{S∗∗h=Λhμh+λ∗∗h,E∗∗h=Λhλ∗∗h(μh+ω)(μh+λ∗∗h),I∗∗h=ωΛhλ∗∗hBh(μh+λ∗∗h),R∗∗h=γ(1−f)ωΛhλ∗∗hμhBh(μh+λ∗∗h),N∗∗h=[μhBh(μh+λ∗∗h)+μh(μh+γ)λ∗∗h+μhωλ∗∗h+γ(1−f)ωλ∗∗h]μhBh(μh+λ∗∗h). \right. $ | (46) |
Putting the above expressions (46) in (44), yields the following quadratic equation with respect to
$ a_h \left(\lambda^{**}_h\right)^2 + b_h\lambda^{**}_h + c_h = 0, $ | (47) |
where the constant coefficients
$ \left\{ah=Λh[μhBh+μh(μh+γ)+μhω+γ(1−f)ω],bh=μ2hBhΛh−μhβhhΦhωΛa+μhω−μh(μh+γ)(μh+ω)¯Da,ch=−μ2hBh¯Da. \right. $ | (48) |
Since,
Similar arguments to those in [39,61] can be used to prove the global asymptotic stability of the unique endemic equilibrium point
Theorem 4.4. If
Replacing
$ \left\{dShdt=Λh−βhhΦhShIhNh−(ˆDa+¯Db)ShNh−μhSh,dEhdt=βhhΦhShIhNh+(ˆDa+¯Db)ShNh−(μh+ω)Eh,dIhdt=ωEh−(μh+γ)Ih,dRhdt=γ(1−f)Ih−μhRh, \right. $ | (49) |
where
$ \widehat{D}_{a} = \beta_{ha}\Phi_a\widehat{I}_{a}. $ | (50) |
The theoretical analysis of subsystem (49) is similar to that of subsystem (42). Denoting by
Theorem 4.5. If
We summarize the existence of the four equilibria of system (19) and their stability properties in the following table.
Equilibria | Conditions of existence | Stability | |
| |
GAS | |
| |
GAS | |
| |
GAS | |
| |
GAS |
We carried out a sensitivity analysis. This allows to identify the parameters that are most influential in determining population dynamics [42,43]. A Latin Hypercube Sampling (LHS) scheme [15,43] samples
Parameters | | | | | |
| | 0.2343 | 0.1922 | 0.0124 | 0.0172 |
| -0.1822 | 0.2005 | 0.1610 | | 0.0180 |
| -0.3116 | | 0.3008 | | 0.0132 |
| | | | -0.0341 | 0.0329 |
| 0.1060 | -0.1786 | -0.1134 | | -0.0148 |
| | | | | |
| -0.0143 | -0.0493 | -0.0453 | -0.0530 | 0.0202 |
| 0.0030 | -0.0099 | 0.284 | -0.0491 | -0.0250 |
| -0.0107 | 0.0630 | 0.0010 | -0.1381 | 0.0356 |
| -0.0218 | 0.0572 | 0.0200 | -0.0509 | -0.0518 |
| -0.1213 | 0.1149 | 0.0410 | -0.1530 | 0.0256 |
| -0.1299 | -0.2465 | | 0.0513 | -0.0613 |
| 0.0463 | -0.0623 | 0.1735 | 0.0108 | 0.0092 |
| 0.0239 | -0.0450 | -0.0185 | -0.325 | -0.0044 |
| 0.0143 | 0.0490 | -0.0125 | 0.0067 | 0.0154 |
| 0.043 | 0.0177 | 0.1003 | -0.0653 | -0.0434 |
| 0.0078 | -0.0041 | -0.0254 | -0.0113 | -0.0506 |
| 0.0133 | 0.0073 | 0.0845 | -0.0410 | -0.0025 |
| 0.0142 | -0.0065 | | -0.0320 | -0.0106 |
| 0.0375 | -0.0581 | 0.0141 | 0.0003 | 0.0263 |
| -0.2682 | 0.3205 | 0.1217 | 0.0220 | 0.0038 |
| -0.3700 | | 0.3747 | -0.0114 | 0.0125 |
| 0.0785 | 0.0106 | 0.0022 | -0.0824 | -0.0129 |
| -0.1816 | 0.2399 | 0.1559 | -0.0395 | -0.0448 |
| 0.0196 | 0.0757 | 0.1389 | -0.0976 | |
| -0.0242 | 0.0984 | 0.0080 | | -0.0030 |
| -0.0214 | -0.0310 | -0.0280 | -0.0071 | 0.0391 |
| -0.0145 | 0.1266 | -0.0036 | | -0.0596 |
| -0.0214 | 0.0150 | 0.0718 | 0.0737 | 0.0339 |
Parameters | | | | |
| | 0.3341 | 0.0602 | 0.0406 |
| -0.1412 | 0.2206 | 0.8767 | -0.0122 |
| -0.3108 | | | -0.0214 |
| | | 0.0180 | 0.0341 |
| 0.0936 | -0.2108 | | -0.0046 |
| | | | |
| 0.0055 | 0.0391 | -0.0337 | -0.0270 |
| -0.0913 | 0.1327 | -0.0923 | -0.0041 |
| -0.0183 | 0.0184 | 0.0608 | -0.0183 |
| -0.0483 | 0.0745 | -0.0953 | -0.0253 |
| -0.1496 | -0.2233 | 0.0116 | 0.0046 |
| 0.0124 | -0.0410 | 0.0286 | -0.0295 |
| 0.0690 | -0.0647 | -0.3869 | 0.0175 |
| -0.0221 | 0.0308 | 0.0099 | 0.0539 |
| 0.0035 | -0.0057 | 0.0042 | 0.0170 |
| -0.2865 | 0.3144 | -0.0275 | -0.0105 |
| -0.3649 | | -0.0063 | -0.0131 |
| -0.2057 | 0.3168 | 0.0372 | 0.0050 |
| -0.0686 | 0.0757 | -0.2270 | |
| -0.0719 | 0.0684 | | -0.0245 |
| 0.0063 | 0.0049 | -0.2936 | 0.0053 |
Parameters | | | | |
| | 0.2046 | 0.1034 | 0.0202 |
| -0.3295 | | 0.3423 | -0.0096 |
| | | | 0.0203 |
| | | | |
| 0.01 | 0.0066 | 0.0254 | -0.0085 |
| -0.0047 | 0.0470 | 0.0421 | -0.0097 |
| -0.0110 | 0.0116 | -0.0052 | 0.0244 |
| -0.1750 | -0.1661 | | -0.0014 |
| 0.0404 | 0.0196 | 0.1127 | -0.0412 |
| -0.0375 | -0.0105 | 0.0071 | 0.0263 |
| 0.0091 | -0.0128 | -0.0147 | 0.0408 |
| -0.0182 | 0.0316 | 0.0038 | -0.0090 |
| 0.0037 | 0.0187 | | -0.0041 |
| -0.0096 | -0.0177 | 0.0319 | -0.0294 |
| -0.2646 | 0.3093 | 0.2130 | 0.0209 |
| -0.3794 | | | 0.0162 |
| 0.0055 | 0.0171 | -0.0102 | -0.0538 |
| -0.0803 | 0.0556 | 0.0875 | |
| -0.0094 | 0.0178 | -0.0178 | 0.0804 |
Parameters | Range | Values | Units | Source |
| Variable | 100 | | N/A |
| Variable | 5 | | N/A |
| Variable | 10 | | N/A |
| 0-1 | 0.33/365 | | [57] |
| 0-1 | 0.4/365 | | Assumed |
| 0-1 | 0.5/365 | | Assumed |
| 0-1 | 0.85/30 | | Assumed [10,46] |
| 0-1 | 1/2.5 | | [50,57] |
| 1-7 | 2.5 | | [50,57] |
| 0-1 | 1/7 | | Assumed |
| 1-14 | 7 | | Assumed |
| 1-5 | 1.2 | | Assumed |
| 1-5 | 1.3 | | Assumed |
| 1/2-1/21 | 1/21 | | [22,50] |
| 1/7-1/14 | 1/14 | | [57] |
| 0-1 | 0.5/365 | | Assumed |
| 10-100 | 50 | | [8] |
| 20-200 | 100 | | Assumed |
| 50-400 | 200 | | Assumed |
| 1/81-1 | 1/61 | | [50] |
| 1-81 | 61 | | [50] |
| 0.4-0.9 | 0.70 | dimensionless | [50,52,57] |
| | | [8] | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable |
In this section, we give numerical simulations that support the theory presented in the previous sections. The simulations are produced by MatLab. While the parameters values for human-to-human transmission are mostly taken from [50,57], we have proposed almost all the parameter values regarding animal-to-human, bat-to-human, environment-to-human, environment-to-animal, environment-to-bat, animal-to-animal, animal-to-bat and bat-to-bat transmission mechanisms.
We numerically illustrate the asymptotic behavior of the full model and the sub-model without the environmental contamination. The GAS of the disease-free equilibrium
We numerically assess the impact of the contaminated environment on the severity/endemicity of EVD, as well as the effects of bats and animals on the long run and severity/endemicity of EVD.
Figure 8 and Figure 9 show the increasing behavior of the full model-related infected component with respect to the indirect effective contact rates
To illustrate the effects of bats and animals on the dynamics of EVD, Figure 9 is the simulation of the model (1) with and without bats on the one hand and with and without animals on the other hand. It can be seen that the incorporation of bats increases significantly the endemic level of EVD in the human population, while the involvement of animals does not.
The main purpose of this paper was to build and analyze a mathematical model for the transmission dynamics of EVD in a complex Ebola virus life ecology. We have then developed and analyzed both theoretically and numerically a new model by taking into account the known, the probable/suspected and the hypothetical mechanisms of transmission of EVD [26,37,51]. The proposed model captures as much as possible the essential patterns of the disease evolution as a three cycle transmission process in the following two ways:
1. It involves the interplay between the epizootic phase (during which the disease circulates periodically amongst non-human primates populations and decimates them), the enzootic phase (during which the disease always remains in fruit bats population) and the epidemic phase (during which the EVD threatens and decimates the human beings).
2. It includes the direct transmission mechanism between and within the three different types of populations which are humans, animals and fruit bats, as well as the indirect route of infection through a contaminated environment.
More precisely, we have extended and enriched the few existing SEIR-type human models for EVD with five additional compartments which model the direct transmissions within/between animal and fruit bat populations as well as the environmental indirect contamination. In this double setting of direct and indirect transmissions, our major findings from the theoretical, numerical and computational point of view read as follows:
From the theoretical perspective, our results are two-fold:
● For the full model with the environmental contamination, we have computed the basic reproduction number
● The sub-model without the environmental contamination exhibits one globally asymptotically stable disease-free equilibrium whenever the host-specific basic reproduction numbers,
From the numerical and computational point of view, the following three facts were addressed:
● In order to assess the role of a contaminated environment on the spreading of EVD, the infected human component resulting from sub-model without the environmental contamination was compared with that of the full model. Similarly, we have considered the sub model without animals on the one hand, and the sub model without bats on the other hand, and found that bats influence more the dynamics of EVD than animals. This is probably because almost all EVD outbreaks were due to consumption and manipulation of fruits bats.
● Global sensitivity analyses were performed to identify the most influential model parameters on the model variables. It shows that the effective contact rate between humans and fruit bats and the bat mortality rate were the most influential parameters on the latent and infected human individuals. This is probably because almost all EVD outbreaks were due to consumption and manipulation of fruits bats.
● Numerical simulations, apart from supporting the theoretical results and the existence of a unique global stable endemic equilibrium for the full model (when
Despite the high level of generalization and complexity of our work, it still offers many opportunities for extensions. Theses include:
(ⅰ) The incorporation of the Ebola-deceased compartments to better capture the transmission mechanisms of EVD during funerals [9].
(ⅱ) The incorporation of the transmission in health care centers in which medical staff can be infected as well [58].
(ⅲ) The incorporation of patches to account for the internationalization of EVD as it is the case in Western Africa [13,23,31].
(ⅳ) The modeling of multi-species transmission mechanism in the case where the same region is threaten by more than one Ebola virus strain.
(ⅴ) The incorporation of the human behavior. For instance, there were evidence of behavioral reaction and self-protection measures: people were scared, they panicked and left care centers, etc...Thus the need to fill the gap of lack of modeling human behavior [11,21]. This important feature calls for a modeling approach based on "Behavioral Epidemiology" developed in [41], which we are already addressing in another work which takes into account self-protection measures driven by human behavior.
(ⅵ) The modeling of some optimal control strategies such as vaccination, isolation, quarantine, treatment, early detection, environmental decontamination.
This work was initiated and mostly developed during the postdoctoral fellowship of the first author (T.B.) at the University of Pretoria in South Africa. (T.B.) and the third author (J.L.) would like to acknowledge the support of the South African Research Chairs Initiative in Mathematical Models and Methods in Bioengineering and Biosciences at the University of Pretoria. The authors are grateful to two anonymous referees whose comments helped to substantially improve this work.
[1] |
Consortium EP, Bernstein BE, Birney E, et al. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74. doi: 10.1038/nature11247
![]() |
[2] | Waddington CH (1942) The epigenotype. Endeavour 1: 18-20. |
[3] |
Lee JT (2011) Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control. Nat Rev Mol Cell Biol 12: 815-826. doi: 10.1038/nrm3231
![]() |
[4] |
Koerner MV, Barlow DP (2010) Genomic imprinting-an epigenetic gene-regulatory model. Curr Opin Genet Dev 20: 164-170. doi: 10.1016/j.gde.2010.01.009
![]() |
[5] |
Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4: 143-153. doi: 10.1038/nrc1279
![]() |
[6] |
Lim PS, Li J, Holloway AF, et al. (2013) Epigenetic regulation of inducible gene expression in the immune system. Immunology 139: 285-293. doi: 10.1111/imm.12100
![]() |
[7] |
Gomes MV, Pelosi GG (2013) Epigenetic vulnerability and the environmental influence on health. Exp Biol Med (Maywood) 238: 859-865. doi: 10.1177/1535370213490630
![]() |
[8] |
Richards EJ (2008) Population epigenetics. Curr Opin Genet Dev 18: 221-226. doi: 10.1016/j.gde.2008.01.014
![]() |
[9] | Gupta S (2013) Epigenetics posited as important for evolutionary success. Nature News. |
[10] |
Liebl AL, Schrey AW, Richards CL, et al. (2013) Patterns of DNA methylation throughout a range expansion of an introduced songbird. Integr Comp Biol 53: 351-358. doi: 10.1093/icb/ict007
![]() |
[11] |
Richards CL, Schrey AW, Pigliucci M (2012) Invasion of diverse habitats by few Japanese knotweed genotypes is correlated with epigenetic differentiation. Ecol Lett 15: 1016-1025. doi: 10.1111/j.1461-0248.2012.01824.x
![]() |
[12] | Luger K, Mader AW, Richmond RK, et al. (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260. |
[13] |
Hager GL, McNally JG, Misteli T (2009) Transcription dynamics. Mol Cell 35: 741-753. doi: 10.1016/j.molcel.2009.09.005
![]() |
[14] |
Reid G, Gallais R, Metivier R (2009) Marking time: the dynamic role of chromatin and covalent modification in transcription. Int J Biochem Cell Biol 41: 155-163. doi: 10.1016/j.biocel.2008.08.028
![]() |
[15] | Wolffe AP (2001) Histone genes. In: Breener S, Miller JH, editors. Encyclopedia of Genetics. San Diego & London: Academic Press. 948-952. |
[16] |
Munshi A, Shafi G, Aliya N, et al. (2009) Histone modifications dictate specific biological readouts. J Genet Genomics 36: 75-88. doi: 10.1016/S1673-8527(08)60094-6
![]() |
[17] |
Peterson CL, Laniel MA (2004) Histones and histone modifications. Curr Biol 14: R546-551. doi: 10.1016/j.cub.2004.07.007
![]() |
[18] |
Tan M, Luo H, Lee S, et al. (2011) Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146: 1016-1028. doi: 10.1016/j.cell.2011.08.008
![]() |
[19] |
Ho JW, Jung YL, Liu T, et al. (2014) Comparative analysis of metazoan chromatin organization. Nature 512: 449-452. doi: 10.1038/nature13415
![]() |
[20] |
Fuchs J, Demidov D, Houben A, et al. (2006) Chromosomal histone modification patterns--from conservation to diversity. Trends Plant Sci 11: 199-208. doi: 10.1016/j.tplants.2006.02.008
![]() |
[21] |
de Ruijter AJ, van Gennip AH, Caron HN, et al. (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370: 737-749. doi: 10.1042/BJ20021321
![]() |
[22] |
Marmorstein R, Roth SY (2001) Histone acetyltransferases: function, structure, and catalysis. Curr Opin Genet Dev 11: 155-161. doi: 10.1016/S0959-437X(00)00173-8
![]() |
[23] |
Marzluff WF, Gongidi P, Woods KR, et al. (2002) The human and mouse replication-dependent histone genes. Genomics 80: 487-498. doi: 10.1006/geno.2002.6850
![]() |
[24] | Boulard M, Bouvet P, Kundu TK, et al. (2007) Histone variant nucleosomes: structure, function and implication in disease. Subcell Biochem 41: 71-89. |
[25] | Talbert PB, Henikoff S (2010) Histone variants--ancient wrap artists of the epigenome. Nat Rev Mol Cell Biol 11: 264-275. |
[26] | Yelagandula R, Stroud H, Holec S, et al. (2014) The histone variant H2A.W defines heterochromatin and promotes chromatin condensation in Arabidopsis. Cell 158: 98-109. |
[27] |
Marino-Ramirez L, Kann MG, Shoemaker BA, et al. (2005) Histone structure and nucleosome stability. Expert Rev Proteomics 2: 719-729. doi: 10.1586/14789450.2.5.719
![]() |
[28] |
Talbert PB, Ahmad K, Almouzni G, et al. (2012) A unified phylogeny-based nomenclature for histone variants. Epigenetics Chromatin 5: 7. doi: 10.1186/1756-8935-5-7
![]() |
[29] |
Clapier CR, Cairns BR (2009) The biology of chromatin remodeling complexes. Annu Rev Biochem 78: 273-304. doi: 10.1146/annurev.biochem.77.062706.153223
![]() |
[30] |
Smith CL, Peterson CL (2005) A conserved Swi2/Snf2 ATPase motif couples ATP hydrolysis to chromatin remodeling. Mol Cell Biol 25: 5880-5892. doi: 10.1128/MCB.25.14.5880-5892.2005
![]() |
[31] | Saha A, Wittmeyer J, Cairns BR (2006) Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Biol 7: 437-447. |
[32] |
Shen W, Xu C, Huang W, et al. (2007) Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. Biochemistry 46: 2100-2110. doi: 10.1021/bi0611208
![]() |
[33] |
Mohrmann L, Verrijzer CP (2005) Composition and functional specificity of SWI2/SNF2 class chromatin remodeling complexes. Biochim Biophys Acta 1681: 59-73. doi: 10.1016/j.bbaexp.2004.10.005
![]() |
[34] |
Bultman S, Gebuhr T, Yee D, et al. (2000) A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 6: 1287-1295. doi: 10.1016/S1097-2765(00)00127-1
![]() |
[35] |
Bestor TH, Verdine GL (1994) DNA methyltransferases. Curr Opin Cell Biol 6: 380-389. doi: 10.1016/0955-0674(94)90030-2
![]() |
[36] |
Ooi SK, O'Donnell AH, Bestor TH (2009) Mammalian cytosine methylation at a glance. J Cell Sci 122: 2787-2791. doi: 10.1242/jcs.015123
![]() |
[37] |
Goll MG, Bestor TH (2005) Eukaryotic cytosine methyltransferases. Annu Rev Biochem 74: 481-514. doi: 10.1146/annurev.biochem.74.010904.153721
![]() |
[38] |
Jeltsch A (2010) Phylogeny of methylomes. Science 328: 837-838. doi: 10.1126/science.1190738
![]() |
[39] |
Lyko F, Foret S, Kucharski R, et al. (2010) The honey bee epigenomes: differential methylation of brain DNA in queens and workers. PLoS Biol 8: e1000506. doi: 10.1371/journal.pbio.1000506
![]() |
[40] |
Feng S, Cokus SJ, Zhang X, et al. (2010) Conservation and divergence of methylation patterning in plants and animals. Proc Natl Acad Sci U S A 107: 8689-8694. doi: 10.1073/pnas.1002720107
![]() |
[41] |
Zemach A, McDaniel IE, Silva P, et al. (2010) Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science 328: 916-919. doi: 10.1126/science.1186366
![]() |
[42] |
Zilberman D, Gehring M, Tran RK, et al. (2007) Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat Genet 39: 61-69. doi: 10.1038/ng1929
![]() |
[43] |
Falckenhayn C, Boerjan B, Raddatz G, et al. (2013) Characterization of genome methylation patterns in the desert locust Schistocerca gregaria. J Exp Biol 216: 1423-1429. doi: 10.1242/jeb.080754
![]() |
[44] |
Fneich S, Dheilly N, Adema C, et al. (2013) 5-methyl-cytosine and 5-hydroxy-methyl-cytosine in the genome of Biomphalaria glabrata, a snail intermediate host of Schistosoma mansoni. Parasit Vectors 6: 167. doi: 10.1186/1756-3305-6-167
![]() |
[45] |
Tahiliani M, Koh KP, Shen Y, et al. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930-935. doi: 10.1126/science.1170116
![]() |
[46] |
Spruijt CG, Gnerlich F, Smits AH, et al. (2013) Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152: 1146-1159. doi: 10.1016/j.cell.2013.02.004
![]() |
[47] |
Almeida RD, Sottile V, Loose M, et al. (2012) Semi-quantitative immunohistochemical detection of 5-hydroxymethyl-cytosine reveals conservation of its tissue distribution between amphibians and mammals. Epigenetics 7: 137-140. doi: 10.4161/epi.7.2.18949
![]() |
[48] |
Almeida RD, Loose M, Sottile V, et al. (2012) 5-hydroxymethyl-cytosine enrichment of non-committed cells is not a universal feature of vertebrate development. Epigenetics 7: 383-389. doi: 10.4161/epi.19375
![]() |
[49] | Wojciechowski M, Rafalski D, Kucharski R, et al. (2014) Insights into DNA hydroxymethylation in the honeybee from in-depth analyses of TET dioxygenase. Open Biol 4. |
[50] |
Khalil AM, Guttman M, Huarte M, et al. (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 106: 11667-11672. doi: 10.1073/pnas.0904715106
![]() |
[51] |
Koziol MJ, Rinn JL (2010) RNA traffic control of chromatin complexes. Curr Opin Genet Dev 20: 142-148. doi: 10.1016/j.gde.2010.03.003
![]() |
[52] |
Mercer TR, Mattick JS (2013) Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol 20: 300-307. doi: 10.1038/nsmb.2480
![]() |
[53] |
Bernstein E, Allis CD (2005) RNA meets chromatin. Genes Dev 19: 1635-1655. doi: 10.1101/gad.1324305
![]() |
[54] |
Gendrel AV, Colot V (2005) Arabidopsis epigenetics: when RNA meets chromatin. Curr Opin Plant Biol 8: 142-147. doi: 10.1016/j.pbi.2005.01.007
![]() |
[55] |
Hall IM, Noma K, Grewal SI (2003) RNA interference machinery regulates chromosome dynamics during mitosis and meiosis in fission yeast. Proc Natl Acad Sci U S A 100: 193-198. doi: 10.1073/pnas.232688099
![]() |
[56] |
Volpe TA, Kidner C, Hall IM, et al. (2002) Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297: 1833-1837. doi: 10.1126/science.1074973
![]() |
[57] |
Grewal SI, Moazed D (2003) Heterochromatin and epigenetic control of gene expression. Science 301: 798-802. doi: 10.1126/science.1086887
![]() |
[58] |
Hannon GJ (2002) RNA interference. Nature 418: 244-251. doi: 10.1038/418244a
![]() |
[59] |
Meister G, Tuschl T (2004) Mechanisms of gene silencing by double-stranded RNA. Nature 431: 343-349. doi: 10.1038/nature02873
![]() |
[60] |
Tomari Y, Zamore PD (2005) Perspective: machines for RNAi. Genes Dev 19: 517-529. doi: 10.1101/gad.1284105
![]() |
[61] |
Quach H, Barreiro LB, Laval G, et al. (2009) Signatures of purifying and local positive selection in human miRNAs. Am J Hum Genet 84: 316-327. doi: 10.1016/j.ajhg.2009.01.022
![]() |
[62] |
Clark AM, Goldstein LD, Tevlin M, et al. (2010) The microRNA miR-124 controls gene expression in the sensory nervous system of Caenorhabditis elegans. Nucleic Acids Res 38: 3780-3793. doi: 10.1093/nar/gkq083
![]() |
[63] |
Aboobaker AA, Tomancak P, Patel N, et al. (2005) Drosophila microRNAs exhibit diverse spatial expression patterns during embryonic development. Proc Natl Acad Sci U S A 102: 18017-18022. doi: 10.1073/pnas.0508823102
![]() |
[64] |
Deo M, Yu JY, Chung KH, et al. (2006) Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev Dyn 235: 2538-2548. doi: 10.1002/dvdy.20847
![]() |
[65] |
Wienholds E, Kloosterman WP, Miska E, et al. (2005) MicroRNA expression in zebrafish embryonic development. Science 309: 310-311. doi: 10.1126/science.1114519
![]() |
[66] | Mor E, Shomron N (2013) Species-specific microRNA regulation influences phenotypic variability: perspectives on species-specific microRNA regulation. Bioessays 35: 881-888. |
[67] | Xi QY, Xiong YY, Wang YM, et al. (2014) Genome-wide discovery of novel and conserved microRNAs in white shrimp (Litopenaeus vannamei). Mol Biol Rep [Epub ahead of print]. |
[68] |
Jain M, Chevala VN, Garg R (2014) Genome-wide discovery and differential regulation of conserved and novel microRNAs in chickpea via deep sequencing. J Exp Bot 65: 5945-5958. doi: 10.1093/jxb/eru333
![]() |
[69] |
Cowled C, Stewart CR, Likic VA, et al. (2014) Characterisation of novel microRNAs in the Black flying fox (Pteropus alecto) by deep sequencing. BMC Genomics 15: 682. doi: 10.1186/1471-2164-15-682
![]() |
[70] |
Kozomara A, Griffiths-Jones S (2014) miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42: D68-73. doi: 10.1093/nar/gkt1181
![]() |
[71] |
Disteche CM (2012) Dosage compensation of the sex chromosomes. Annu Rev Genet 46: 537-560. doi: 10.1146/annurev-genet-110711-155454
![]() |
[72] |
Lyon MF (1961) Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190: 372-373. doi: 10.1038/190372a0
![]() |
[73] |
Deakin JE (2013) Marsupial X chromosome inactivation: past, present and future. Aust J Zool 61: 13-23. doi: 10.1071/ZO12113
![]() |
[74] |
Glas R, Marshall Graves JA, Toder R, et al. (1999) Cross-species chromosome painting between human and marsupial directly demonstrates the ancient region of the mammalian X. Mamm Genome 10: 1115-1116. doi: 10.1007/s003359901174
![]() |
[75] |
Graves JA (1995) The evolution of mammalian sex chromosomes and the origin of sex determining genes. Philos Trans R Soc Lond B Biol Sci 350: 305-311; discussion 311-302. doi: 10.1098/rstb.1995.0166
![]() |
[76] |
Grant J, Mahadevaiah SK, Khil P, et al. (2012) Rsx is a metatherian RNA with Xist-like properties in X-chromosome inactivation. Nature 487: 254-258. doi: 10.1038/nature11171
![]() |
[77] |
Borsani G, Tonlorenzi R, Simmler MC, et al. (1991) Characterization of a murine gene expressed from the inactive X chromosome. Nature 351: 325-329. doi: 10.1038/351325a0
![]() |
[78] |
Heard E (2005) Delving into the diversity of facultative heterochromatin: the epigenetics of the inactive X chromosome. Curr Opin Genet Dev 15: 482-489. doi: 10.1016/j.gde.2005.08.009
![]() |
[79] |
Koina E, Chaumeil J, Greaves IK, et al. (2009) Specific patterns of histone marks accompany X chromosome inactivation in a marsupial. Chromosome Res 17: 115-126. doi: 10.1007/s10577-009-9020-7
![]() |
[80] |
Rens W, Wallduck MS, Lovell FL, et al. (2010) Epigenetic modifications on X chromosomes in marsupial and monotreme mammals and implications for evolution of dosage compensation. Proc Natl Acad Sci U S A 107: 17657-17662. doi: 10.1073/pnas.0910322107
![]() |
[81] |
Zakharova IS, Shevchenko AI, Shilov AG, et al. (2011) Histone H3 trimethylation at lysine 9 marks the inactive metaphase X chromosome in the marsupial Monodelphis domestica. Chromosoma 120: 177-183. doi: 10.1007/s00412-010-0300-y
![]() |
[82] |
Chaumeil J, Waters PD, Koina E, et al. (2011) Evolution from XIST-independent to XIST-controlled X-chromosome inactivation: epigenetic modifications in distantly related mammals. PLoS One 6: e19040. doi: 10.1371/journal.pone.0019040
![]() |
[83] |
Mahadevaiah SK, Royo H, VandeBerg JL, et al. (2009) Key features of the X inactivation process are conserved between marsupials and eutherians. Curr Biol 19: 1478-1484. doi: 10.1016/j.cub.2009.07.041
![]() |
[84] |
Plath K, Fang J, Mlynarczyk-Evans SK, et al. (2003) Role of histone H3 lysine 27 methylation in X inactivation. Science 300: 131-135. doi: 10.1126/science.1084274
![]() |
[85] |
Zhao J, Sun BK, Erwin JA, et al. (2008) Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322: 750-756. doi: 10.1126/science.1163045
![]() |
[86] |
Costanzi C, Pehrson JR (1998) Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 393: 599-601. doi: 10.1038/31275
![]() |
[87] |
Hornecker JL, Samollow PB, Robinson ES, et al. (2007) Meiotic sex chromosome inactivation in the marsupial Monodelphis domestica. Genesis 45: 696-708. doi: 10.1002/dvg.20345
![]() |
[88] |
Kaslow DC, Migeon BR, Persico MG, et al. (1987) Molecular studies of marsupial X chromosomes reveal limited sequence homology of mammalian X-linked genes. Genomics 1: 19-28. doi: 10.1016/0888-7543(87)90100-5
![]() |
[89] |
Loebel DA, Johnston PG (1996) Methylation analysis of a marsupial X-linked CpG island by bisulfite genomic sequencing. Genome Res 6: 114-123. doi: 10.1101/gr.6.2.114
![]() |
[90] | Wang X, Douglas KC, Vandeberg JL, et al. (2013) Chromosome-wide profiling of X-chromosome inactivation and epigenetic states in fetal brain and placenta of the opossum, Monodelphis domestica. Genome Res 24: 70-83. |
[91] |
Loebel DA, Johnston PG (1993) Analysis of DNase 1 sensitivity and methylation of active and inactive X chromosomes of kangaroos (Macropus robustus) by in situ nick translation. Chromosoma 102: 81-87. doi: 10.1007/BF00356024
![]() |
[92] |
Hellman A, Chess A (2007) Gene body-specific methylation on the active X chromosome. Science 315: 1141-1143. doi: 10.1126/science.1136352
![]() |
[93] |
Deakin JE, Hore TA, Koina E, et al. (2008) The status of dosage compensation in the multiple X chromosomes of the platypus. PLoS Genet 4: e1000140. doi: 10.1371/journal.pgen.1000140
![]() |
[94] |
Livernois AM, Waters SA, Deakin JE, et al. (2013) Independent evolution of transcriptional inactivation on sex chromosomes in birds and mammals. PLoS Genet 9: e1003635. doi: 10.1371/journal.pgen.1003635
![]() |
[95] | Livernois AM (2013) Evolution of transcriptional inactivation on sex chromosomes in birds and mammals: The Australian National University. 145. |
[96] |
Kondilis-Mangum HD, Wade PA (2013) Epigenetics and the adaptive immune response. Mol Aspects Med 34: 813-825. doi: 10.1016/j.mam.2012.06.008
![]() |
[97] |
Seita J, Weissman IL (2010) Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med 2: 640-653. doi: 10.1002/wsbm.86
![]() |
[98] |
Zediak VP, Wherry EJ, Berger SL (2011) The contribution of epigenetic memory to immunologic memory. Curr Opin Genet Dev 21: 154-159. doi: 10.1016/j.gde.2011.01.016
![]() |
[99] |
Araki Y, Wang Z, Zang C, et al. (2009) Genome-wide Analysis of Histone Methylation Reveals Chromatin State-Based Regulation of Gene Transcription and Function of Memory CD8(+) T Cells. Immunity 30: 912-925. doi: 10.1016/j.immuni.2009.05.006
![]() |
[100] |
Barski A, Cuddapah S, Cui K, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837. doi: 10.1016/j.cell.2007.05.009
![]() |
[101] |
Roh TY, Cuddapah S, Cui K, et al. (2006) The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci U S A 103: 15782-15787. doi: 10.1073/pnas.0607617103
![]() |
[102] |
Roh TY, Cuddapah S, Zhao K (2005) Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev 19: 542-552. doi: 10.1101/gad.1272505
![]() |
[103] |
Roh TY, Ngau WC, Cui K, et al. (2004) High-resolution genome-wide mapping of histone modifications. Nat Biotechnol 22: 1013-1016. doi: 10.1038/nbt990
![]() |
[104] |
Schones DE, Cui K, Cuddapah S, et al. (2008) Dynamic regulation of nucleosome positioning in the human genome. Cell 132: 887-898. doi: 10.1016/j.cell.2008.02.022
![]() |
[105] |
Wang Z, Zang C, Rosenfeld JA, et al. (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40: 897-903. doi: 10.1038/ng.154
![]() |
[106] |
Lim PS, Shannon MF, Hardy K (2010) Epigenetic control of inducible gene expression in the immune system. Epigenomics 2: 775-795. doi: 10.2217/epi.10.55
![]() |
[107] |
Wei G, Wei L, Zhu J, et al. (2009) Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30: 155-167. doi: 10.1016/j.immuni.2008.12.009
![]() |
[108] |
Lim PS, Hardy K, Bunting KL, et al. (2009) Defining the chromatin signature of inducible genes in T cells. Genome Biol 10: R107. doi: 10.1186/gb-2009-10-10-r107
![]() |
[109] |
Smith AE, Chronis C, Christodoulakis M, et al. (2009) Epigenetics of human T cells during the G0-->G1 transition. Genome Res 19: 1325-1337. doi: 10.1101/gr.085530.108
![]() |
[110] |
Barski A, Jothi R, Cuddapah S, et al. (2009) Chromatin poises miRNA- and protein-coding genes for expression. Genome Res 19: 1742-1751. doi: 10.1101/gr.090951.109
![]() |
[111] |
Belov K, Sanderson CE, Deakin JE, et al. (2007) Characterization of the opossum immune genome provides insights into the evolution of the mammalian immune system. Genome Res 17: 982-991. doi: 10.1101/gr.6121807
![]() |
[112] |
Deakin JE, Belov K, Curach NC, et al. (2005) High levels of variability in immune response using antigens from two reproductive proteins in brushtail possums. Wildlife Res 32: 1-6. doi: 10.1071/WR03107
![]() |
[113] | Yadav M (1971) The transmissions of antibodies across the gut of pouch-young marsupials. Immunology 21: 839-851. |
[114] |
Duncan LG, Nair SV, Deane EM (2009) The marsupial CD8 gene locus: molecular cloning and expression analysis of the alpha and beta sequences in the gray short-tailed opossum (Monodelphis domestica) and the tammar wallaby (Macropus eugenii). Vet Immunol Immunopathol 129: 14-27. doi: 10.1016/j.vetimm.2008.12.003
![]() |
[115] |
Wong ES, Papenfuss AT, Belov K (2011) Immunome database for marsupials and monotremes. BMC Immunol 12: 48. doi: 10.1186/1471-2172-12-48
![]() |
[116] |
Duncan L, Webster K, Gupta V, et al. (2010) Molecular characterisation of the CD79a and CD79b subunits of the B cell receptor complex in the gray short-tailed opossum (Monodelphis domestica) and tammar wallaby (Macropus eugenii): Delayed B cell immunocompetence in marsupial neonates. Vet Immunol Immunopathol 136: 235-247. doi: 10.1016/j.vetimm.2010.03.013
![]() |
[117] |
Duncan LG, Nair SV, Deane EM (2012) Immunohistochemical localization of T-lymphocyte subsets in the developing lymphoid tissues of the tammar wallaby (Macropus eugenii). Dev Comp Immunol 38: 475-486. doi: 10.1016/j.dci.2012.06.015
![]() |
[118] |
Hussein MF, Badir N, Elridi R, et al. (1978) Effect of Seasonal-Variation on Lymphoid-Tissues of Lizards, Mabuya-Quinquetaeniata Licht and Uromastyx-Aegyptia Forsk. Dev Comp Immunol 2: 469-478. doi: 10.1016/S0145-305X(78)80008-1
![]() |
[119] |
Hussein MF, Badir N, Elridi R, et al. (1979) Lymphoid-Tissues of the Snake, Spalerosophis-Diadema, in the Different Seasons. Dev Comp Immunol 3: 77-88. doi: 10.1016/S0145-305X(79)80008-7
![]() |
[120] |
Hussein MF, Badir N, Ridi RE, et al. (1978) Differential Effect of Seasonal-Variation on Lymphoid-Tissue of Lizard, Chalcides-Ocellatus. Dev Comp Immunol 2: 297-309. doi: 10.1016/S0145-305X(78)80072-X
![]() |
[121] |
Elridi R, Badir N, Elrouby S (1981) Effect of Seasonal-Variations on the Immune-System of the Snake, Psammophis-Schokari. J Exp Zool 216: 357-365. doi: 10.1002/jez.1402160303
![]() |
[122] |
Hussein MF, Badir N, Elridi R, et al. (1979) Effect of Seasonal-Variation on Immune System of the Lizard, Scincus-Scincus. J Exp Zool 209: 91-96. doi: 10.1002/jez.1402090111
![]() |
[123] |
Alfoldi J, Di Palma F, Grabherr M, et al. (2011) The genome of the green anole lizard and a comparative analysis with birds and mammals. Nature 477: 587-591. doi: 10.1038/nature10390
![]() |
[124] |
Castoe TA, de Koning AP, Hall KT, et al. (2013) The Burmese python genome reveals the molecular basis for extreme adaptation in snakes. Proc Natl Acad Sci U S A 110: 20645-20650. doi: 10.1073/pnas.1314475110
![]() |
[125] |
Shaffer HB, Minx P, Warren DE, et al. (2013) The western painted turtle genome, a model for the evolution of extreme physiological adaptations in a slowly evolving lineage. Genome Biol 14: R28. doi: 10.1186/gb-2013-14-3-r28
![]() |
[126] |
Vonk FJ, Casewell NR, Henkel CV, et al. (2013) The king cobra genome reveals dynamic gene evolution and adaptation in the snake venom system. Proc Natl Acad Sci U S A 110: 20651-20656. doi: 10.1073/pnas.1314702110
![]() |
[127] |
Wang Z, Pascual-Anaya J, Zadissa A, et al. (2013) The draft genomes of soft-shell turtle and green sea turtle yield insights into the development and evolution of the turtle-specific body plan. Nat Genet 45: 701-706. doi: 10.1038/ng.2615
![]() |
[128] |
McPherson FJ, Chenoweth PJ (2012) Mammalian sexual dimorphism. Anim Reprod Sci 131: 109-122. doi: 10.1016/j.anireprosci.2012.02.007
![]() |
[129] |
Kuroki S, Matoba S, Akiyoshi M, et al. (2013) Epigenetic regulation of mouse sex determination by the histone demethylase Jmjd1a. Science 341: 1106-1109. doi: 10.1126/science.1239864
![]() |
[130] | Charnier M (1966) [Action of temperature on the sex ratio in the Agama agama (Agamidae, Lacertilia) embryo]. C R Seances Soc Biol Fil 160: 620-622. |
[131] |
Piferrer F (2013) Epigenetics of sex determination and gonadogenesis. Dev Dyn 242: 360-370. doi: 10.1002/dvdy.23924
![]() |
[132] |
Gorelick R (2003) Evolution of dioecy and sex chromosomes via methylation driving Muller's ratchet. Biol J Linn Soc 80: 353-368. doi: 10.1046/j.1095-8312.2003.00244.x
![]() |
[133] |
Eggert C (2004) Sex determination: the amphibian models. Reprod Nutr Dev 44: 539-549. doi: 10.1051/rnd:2004062
![]() |
[134] |
Martinez-Arguelles DB, Papadopoulos V (2010) Epigenetic regulation of the expression of genes involved in steroid hormone biosynthesis and action. Steroids 75: 467-476. doi: 10.1016/j.steroids.2010.02.004
![]() |
[135] |
Zhang X, Ho SM (2011) Epigenetics meets endocrinology. J Mol Endocrinol 46: R11-32. doi: 10.1677/JME-10-0053
![]() |
[136] |
Navarro-Martin L, Vinas J, Ribas L, et al. (2011) DNA methylation of the gonadal aromatase (cyp19a) promoter is involved in temperature-dependent sex ratio shifts in the European sea bass. PLoS Genet 7: e1002447. doi: 10.1371/journal.pgen.1002447
![]() |
[137] | Ramsey M, Shoemaker C, Crews D (2007) Gonadal expression of Sf1 and aromatase during sex determination in the red-eared slider turtle (Trachemys scripta), a reptile with temperature-dependent sex determination. Differentiation 75: 978-991. |
[138] |
Matsumoto Y, Buemio A, Chu R, et al. (2013) Epigenetic control of gonadal aromatase (cyp19a1) in temperature-dependent sex determination of red-eared slider turtles. PLoS One 8: e63599. doi: 10.1371/journal.pone.0063599
![]() |
[139] |
Shao C, Li Q, Chen S, et al. (2014) Epigenetic modification and inheritance in sexual reversal of fish. Genome Res 24: 604-615. doi: 10.1101/gr.162172.113
![]() |
[140] |
Chen S, Zhang G, Shao C, et al. (2014) Whole-genome sequence of a flatfish provides insights into ZW sex chromosome evolution and adaptation to a benthic lifestyle. Nat Genet 46: 253-260. doi: 10.1038/ng.2890
![]() |
1. | Anecia D. Gentles, Sarah Guth, Carly Rozins, Cara E. Brook, A review of mechanistic models of viral dynamics in bat reservoirs for zoonotic disease, 2020, 114, 2047-7724, 407, 10.1080/20477724.2020.1833161 | |
2. | A. Mhlanga, Dynamical analysis and control strategies in modelling Ebola virus disease, 2019, 2019, 1687-1847, 10.1186/s13662-019-2392-x | |
3. | R. Anguelov, T. Berge, M. Chapwanya, J.K. Djoko, P. Kama, J. M.-S. Lubuma, Y. Terefe, Nonstandard finite difference method revisited and application to the Ebola virus disease transmission dynamics, 2020, 26, 1023-6198, 818, 10.1080/10236198.2020.1792892 | |
4. | Muhammad Rafiq, Waheed Ahmad, Mujahid Abbas, Dumitru Baleanu, A reliable and competitive mathematical analysis of Ebola epidemic model, 2020, 2020, 1687-1847, 10.1186/s13662-020-02994-2 | |
5. | Leontine Nkague Nkamba, Thomas Timothee Manga, Franklin Agouanet, Martin Luther Mann Manyombe, Mathematical model to assess vaccination and effective contact rate impact in the spread of tuberculosis, 2019, 13, 1751-3758, 26, 10.1080/17513758.2018.1563218 | |
6. | Gregory N. Price, Does Productivity in the Formal Food Sector Drive Human Ebola Virus Infections in Sub‐Saharan Africa?, 2019, 31, 1017-6772, 167, 10.1111/1467-8268.12375 | |
7. | Felix B. He, Krister Melén, Laura Kakkola, Ilkka Julkunen, 2020, Chapter 4, 978-1-78985-549-4, 10.5772/intechopen.86749 | |
8. | T. Berge, A. J. Ouemba Tassé, H. M. Tenkam, J. Lubuma, Mathematical modeling of contact tracing as a control strategy of Ebola virus disease, 2018, 11, 1793-5245, 1850093, 10.1142/S1793524518500936 | |
9. | Suliman Jamiel M. Abdalla, Faraimunashe Chirove, Keshlan S. Govinder, A systematic review of mathematical models of the Ebola virus disease, 2022, 42, 0228-6203, 814, 10.1080/02286203.2021.1983745 | |
10. | Peiyu Chen, Wenhui Fan, Xudong Guo, Constantinos Siettos, A hybrid simulation model to study the impact of combined interventions on Ebola epidemic, 2021, 16, 1932-6203, e0254044, 10.1371/journal.pone.0254044 | |
11. | Ashley Hydrick, Elizabeth Dunn, 2022, Chapter 26-1, 978-3-319-51761-2, 1, 10.1007/978-3-319-51761-2_26-1 | |
12. | Calvin Tadmon, Jacques Ndé Kengne, Mathematical analysis of a model of Ebola disease with control measures, 2022, 15, 1793-5245, 10.1142/S1793524522500486 | |
13. | Ashley Hydrick, Elizabeth Dunn, 2022, Chapter 26, 978-3-319-91874-7, 599, 10.1007/978-3-319-91875-4_26 | |
14. | Sena Mursel, Nathaniel Alter, Lindsay Slavit, Anna Smith, Paolo Bocchini, Javier Buceta, Alberto d’Onofrio, Estimation of Ebola’s spillover infection exposure in Sierra Leone based on sociodemographic and economic factors, 2022, 17, 1932-6203, e0271886, 10.1371/journal.pone.0271886 | |
15. | A. J. OUEMBA TASSÉ, B. TSANOU, J. LUBUMA, JEAN LOUIS WOUKENG, FRANCIS SIGNING, EBOLA VIRUS DISEASE DYNAMICS WITH SOME PREVENTIVE MEASURES: A CASE STUDY OF THE 2018–2020 KIVU OUTBREAK, 2022, 30, 0218-3390, 113, 10.1142/S0218339022500048 | |
16. | Calvin Tadmon, Jacques Ndé Kengne, Mathematical modelling and nonstandard finite scheme analysis for an Ebola model transmission with information and voluntary isolation, 2022, 28, 1023-6198, 299, 10.1080/10236198.2022.2042524 | |
17. | JAMES ANDRAWUS, ABDULLAHI YUSUF, UMAR TASIU MUSTAPHA, ALI S. ALSHOMRANI, DUMITRU BALEANU, UNRAVELING THE DYNAMICS OF EBOLA VIRUS WITH CONTACT TRACING AS CONTROL STRATEGY, 2023, 31, 0218-348X, 10.1142/S0218348X2340159X | |
18. | Calvin Tadmon, Jacques Ndé Kengne, Enriched spatiotemporal dynamics of a model of Ebola transmission with a composite incidence function and density-independent treatment, 2024, 79, 14681218, 104118, 10.1016/j.nonrwa.2024.104118 | |
19. | Huarong Ren, Rui Xu, Prevention and control of Ebola virus transmission: mathematical modelling and data fitting, 2024, 89, 0303-6812, 10.1007/s00285-024-02122-8 | |
20. | Ikram Ullah, Imtiaz Ahmad, Nigar Ali, Ihtisham Ul Haq, Mohammad Idrees, Mohammed Daher Albalwi, Mehmet Yavuz, Mathematical Modeling and Analysis of Ebola Virus Disease Dynamics: Implications for Intervention Strategies and Healthcare Resource Optimization, 2024, 29, 2297-8747, 94, 10.3390/mca29050094 | |
21. | Joshua Kiddy Kwasi Asamoah, Isaac K. Adu, Fredrick A. Wireko, Stephen B. Lassong, Fatmawati Fatmawati, Modeling the effect of memory on the spread of Query fever considering humans, animals and the environment, 2025, 11, 2363-6203, 10.1007/s40808-025-02354-7 |
Year | Country | Species | Starting date | Source of infection |
1976 | DRC | Zaire | September | Unknown. Index case was a mission school teacher. |
1976 | Sudan | Sudan | June | Worker in a cotton factory. |
Evidence of bats at site. | ||||
1977 | DRC | Zaire | June | Unknown (retrospective). |
1979 | Sudan | Sudan | July | Worker in cotton factory. |
Evidence of bats at site. | ||||
1994 | Gabon | Zaire | December | Gold-mining camps. |
Evidence of bats at site. | ||||
1994 | Ivory Coast | Ivory Coast | November | Scientist performing autopsy on a dead wild chimpanzee. |
1995 | Liberia | Ivory Coast | December | Unknown. Refugee from civil war. |
1995 | DRC | Zaire | January | Index case worked in a forest adjoining the city. |
1996 | Gabon | Zaire | January | People involved in the butchering of a dead chimpanzee. |
1996-1997 | Gabon | Zaire | July | Index case was a hunter living in a forest camp. |
2000-2001 | Uganda | Sudan | September | Unknown. |
2001-2002 | Gabon | Zaire | October | Contact with dead or butchered apes or other wildlife. |
2001-2002 | DRC | Zaire | October | Contact with dead or butchered apes or other wildlife. |
2002-2003 | DRC | Zaire | December | Contact with dead or butchered apes or other wildlife. |
2003 | DRC | Zaire | November | Contact with dead or butchered apes or other wildlife. |
2004 | Sudan | Sudan | May | Unknown. |
2005 | DRC | Zaire | April | unknown. |
2007 | DRC | Zaire | December | Contact with dead or butchered apes or other wildlife. |
2007 | Uganda | Bundibugyo | December | Unknown. |
2008 | DRC | Zaire | December | Index case was a village chief and a hunter. |
2012 | Uganda | Bundibugyo | June | Index case was a secondary school teacher in Ibanda district. |
2012 | DRC | Zaire | June | Index case was a hunter living in a forest camp. |
2013-2015 | Guinea | Zaire | December | Contact with bats or fruits contaminated by bat droppings. |
2014-2015 | Liberia | Zaire | April | Index case was transported from Guinea. |
2014-2015 | Sierra Leone | Zaire | April | A traditional healer, treating Ebola patients from Guinea. |
2014 | DRC | Zaire | August | Pregnant women who butchered a bush animal. |
Symbols | Biological interpretations |
|
Recruitment rate of susceptible humans, animals and bats, respectively. |
|
Natural mortality rate of humans, animals and bats, respectively. |
|
Virulence of Ebola virus in the corpse of the dead humans. |
|
Mean duration of time that elapse after death before a human cadaver is completely buried. |
|
Modification parameter of infectiousness due to dead human individuals. |
|
Mean duration of time that elapse after death before an animal's cadaver is completely cleared out. |
|
Modification parameter of infectiousness due to dead animals individuals. |
|
Virulence of Ebola virus in the corpse of dead animals. |
|
Incubation rate of human individuals. |
|
Removal rate from infectious compartment due to either to disease induced death, or by recovery. |
|
Death rate of infected animals. |
|
Shedding rates of Ebola virus in the environment by humans, animals and bats, respectively. |
|
Mean duration of time that elapse before the complete clearance of Ebola virus in humans. |
|
Modification parameter of contact rate of recovered humans (sexual activity of recovered). |
in the semen/breast milk of a recovered man/woman. | |
|
Proortion of removed human individuals who die due EVD (i.e. case fatality rate). |
|
Virus 50 % infectious dose, sufficient to cause EVD. |
|
Contact rate between susceptible humans and infected humans. |
|
Contact rate between susceptible humans and bats. |
|
Contact rate between susceptible humans and Ebola viruses. |
|
Contact rate between susceptible humans and infected animals. |
|
Contact rate between susceptible bats and infectious bats. |
|
Contact rate between susceptible animals and infectious bats. |
|
Contact rate between susceptible bats and and Ebola viruses. |
|
Contact rate between susceptible and infected animals. |
|
Contact rate between susceptible animals and Ebola viruses. |
Equilibria | Conditions of existence | Stability | |
| |
GAS | |
| |
GAS | |
| |
GAS | |
| |
GAS |
Parameters | | | | | |
| | 0.2343 | 0.1922 | 0.0124 | 0.0172 |
| -0.1822 | 0.2005 | 0.1610 | | 0.0180 |
| -0.3116 | | 0.3008 | | 0.0132 |
| | | | -0.0341 | 0.0329 |
| 0.1060 | -0.1786 | -0.1134 | | -0.0148 |
| | | | | |
| -0.0143 | -0.0493 | -0.0453 | -0.0530 | 0.0202 |
| 0.0030 | -0.0099 | 0.284 | -0.0491 | -0.0250 |
| -0.0107 | 0.0630 | 0.0010 | -0.1381 | 0.0356 |
| -0.0218 | 0.0572 | 0.0200 | -0.0509 | -0.0518 |
| -0.1213 | 0.1149 | 0.0410 | -0.1530 | 0.0256 |
| -0.1299 | -0.2465 | | 0.0513 | -0.0613 |
| 0.0463 | -0.0623 | 0.1735 | 0.0108 | 0.0092 |
| 0.0239 | -0.0450 | -0.0185 | -0.325 | -0.0044 |
| 0.0143 | 0.0490 | -0.0125 | 0.0067 | 0.0154 |
| 0.043 | 0.0177 | 0.1003 | -0.0653 | -0.0434 |
| 0.0078 | -0.0041 | -0.0254 | -0.0113 | -0.0506 |
| 0.0133 | 0.0073 | 0.0845 | -0.0410 | -0.0025 |
| 0.0142 | -0.0065 | | -0.0320 | -0.0106 |
| 0.0375 | -0.0581 | 0.0141 | 0.0003 | 0.0263 |
| -0.2682 | 0.3205 | 0.1217 | 0.0220 | 0.0038 |
| -0.3700 | | 0.3747 | -0.0114 | 0.0125 |
| 0.0785 | 0.0106 | 0.0022 | -0.0824 | -0.0129 |
| -0.1816 | 0.2399 | 0.1559 | -0.0395 | -0.0448 |
| 0.0196 | 0.0757 | 0.1389 | -0.0976 | |
| -0.0242 | 0.0984 | 0.0080 | | -0.0030 |
| -0.0214 | -0.0310 | -0.0280 | -0.0071 | 0.0391 |
| -0.0145 | 0.1266 | -0.0036 | | -0.0596 |
| -0.0214 | 0.0150 | 0.0718 | 0.0737 | 0.0339 |
Parameters | | | | |
| | 0.3341 | 0.0602 | 0.0406 |
| -0.1412 | 0.2206 | 0.8767 | -0.0122 |
| -0.3108 | | | -0.0214 |
| | | 0.0180 | 0.0341 |
| 0.0936 | -0.2108 | | -0.0046 |
| | | | |
| 0.0055 | 0.0391 | -0.0337 | -0.0270 |
| -0.0913 | 0.1327 | -0.0923 | -0.0041 |
| -0.0183 | 0.0184 | 0.0608 | -0.0183 |
| -0.0483 | 0.0745 | -0.0953 | -0.0253 |
| -0.1496 | -0.2233 | 0.0116 | 0.0046 |
| 0.0124 | -0.0410 | 0.0286 | -0.0295 |
| 0.0690 | -0.0647 | -0.3869 | 0.0175 |
| -0.0221 | 0.0308 | 0.0099 | 0.0539 |
| 0.0035 | -0.0057 | 0.0042 | 0.0170 |
| -0.2865 | 0.3144 | -0.0275 | -0.0105 |
| -0.3649 | | -0.0063 | -0.0131 |
| -0.2057 | 0.3168 | 0.0372 | 0.0050 |
| -0.0686 | 0.0757 | -0.2270 | |
| -0.0719 | 0.0684 | | -0.0245 |
| 0.0063 | 0.0049 | -0.2936 | 0.0053 |
Parameters | | | | |
| | 0.2046 | 0.1034 | 0.0202 |
| -0.3295 | | 0.3423 | -0.0096 |
| | | | 0.0203 |
| | | | |
| 0.01 | 0.0066 | 0.0254 | -0.0085 |
| -0.0047 | 0.0470 | 0.0421 | -0.0097 |
| -0.0110 | 0.0116 | -0.0052 | 0.0244 |
| -0.1750 | -0.1661 | | -0.0014 |
| 0.0404 | 0.0196 | 0.1127 | -0.0412 |
| -0.0375 | -0.0105 | 0.0071 | 0.0263 |
| 0.0091 | -0.0128 | -0.0147 | 0.0408 |
| -0.0182 | 0.0316 | 0.0038 | -0.0090 |
| 0.0037 | 0.0187 | | -0.0041 |
| -0.0096 | -0.0177 | 0.0319 | -0.0294 |
| -0.2646 | 0.3093 | 0.2130 | 0.0209 |
| -0.3794 | | | 0.0162 |
| 0.0055 | 0.0171 | -0.0102 | -0.0538 |
| -0.0803 | 0.0556 | 0.0875 | |
| -0.0094 | 0.0178 | -0.0178 | 0.0804 |
Parameters | Range | Values | Units | Source |
| Variable | 100 | | N/A |
| Variable | 5 | | N/A |
| Variable | 10 | | N/A |
| 0-1 | 0.33/365 | | [57] |
| 0-1 | 0.4/365 | | Assumed |
| 0-1 | 0.5/365 | | Assumed |
| 0-1 | 0.85/30 | | Assumed [10,46] |
| 0-1 | 1/2.5 | | [50,57] |
| 1-7 | 2.5 | | [50,57] |
| 0-1 | 1/7 | | Assumed |
| 1-14 | 7 | | Assumed |
| 1-5 | 1.2 | | Assumed |
| 1-5 | 1.3 | | Assumed |
| 1/2-1/21 | 1/21 | | [22,50] |
| 1/7-1/14 | 1/14 | | [57] |
| 0-1 | 0.5/365 | | Assumed |
| 10-100 | 50 | | [8] |
| 20-200 | 100 | | Assumed |
| 50-400 | 200 | | Assumed |
| 1/81-1 | 1/61 | | [50] |
| 1-81 | 61 | | [50] |
| 0.4-0.9 | 0.70 | dimensionless | [50,52,57] |
| | | [8] | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable |
Year | Country | Species | Starting date | Source of infection |
1976 | DRC | Zaire | September | Unknown. Index case was a mission school teacher. |
1976 | Sudan | Sudan | June | Worker in a cotton factory. |
Evidence of bats at site. | ||||
1977 | DRC | Zaire | June | Unknown (retrospective). |
1979 | Sudan | Sudan | July | Worker in cotton factory. |
Evidence of bats at site. | ||||
1994 | Gabon | Zaire | December | Gold-mining camps. |
Evidence of bats at site. | ||||
1994 | Ivory Coast | Ivory Coast | November | Scientist performing autopsy on a dead wild chimpanzee. |
1995 | Liberia | Ivory Coast | December | Unknown. Refugee from civil war. |
1995 | DRC | Zaire | January | Index case worked in a forest adjoining the city. |
1996 | Gabon | Zaire | January | People involved in the butchering of a dead chimpanzee. |
1996-1997 | Gabon | Zaire | July | Index case was a hunter living in a forest camp. |
2000-2001 | Uganda | Sudan | September | Unknown. |
2001-2002 | Gabon | Zaire | October | Contact with dead or butchered apes or other wildlife. |
2001-2002 | DRC | Zaire | October | Contact with dead or butchered apes or other wildlife. |
2002-2003 | DRC | Zaire | December | Contact with dead or butchered apes or other wildlife. |
2003 | DRC | Zaire | November | Contact with dead or butchered apes or other wildlife. |
2004 | Sudan | Sudan | May | Unknown. |
2005 | DRC | Zaire | April | unknown. |
2007 | DRC | Zaire | December | Contact with dead or butchered apes or other wildlife. |
2007 | Uganda | Bundibugyo | December | Unknown. |
2008 | DRC | Zaire | December | Index case was a village chief and a hunter. |
2012 | Uganda | Bundibugyo | June | Index case was a secondary school teacher in Ibanda district. |
2012 | DRC | Zaire | June | Index case was a hunter living in a forest camp. |
2013-2015 | Guinea | Zaire | December | Contact with bats or fruits contaminated by bat droppings. |
2014-2015 | Liberia | Zaire | April | Index case was transported from Guinea. |
2014-2015 | Sierra Leone | Zaire | April | A traditional healer, treating Ebola patients from Guinea. |
2014 | DRC | Zaire | August | Pregnant women who butchered a bush animal. |
Symbols | Biological interpretations |
|
Recruitment rate of susceptible humans, animals and bats, respectively. |
|
Natural mortality rate of humans, animals and bats, respectively. |
|
Virulence of Ebola virus in the corpse of the dead humans. |
|
Mean duration of time that elapse after death before a human cadaver is completely buried. |
|
Modification parameter of infectiousness due to dead human individuals. |
|
Mean duration of time that elapse after death before an animal's cadaver is completely cleared out. |
|
Modification parameter of infectiousness due to dead animals individuals. |
|
Virulence of Ebola virus in the corpse of dead animals. |
|
Incubation rate of human individuals. |
|
Removal rate from infectious compartment due to either to disease induced death, or by recovery. |
|
Death rate of infected animals. |
|
Shedding rates of Ebola virus in the environment by humans, animals and bats, respectively. |
|
Mean duration of time that elapse before the complete clearance of Ebola virus in humans. |
|
Modification parameter of contact rate of recovered humans (sexual activity of recovered). |
in the semen/breast milk of a recovered man/woman. | |
|
Proortion of removed human individuals who die due EVD (i.e. case fatality rate). |
|
Virus 50 % infectious dose, sufficient to cause EVD. |
|
Contact rate between susceptible humans and infected humans. |
|
Contact rate between susceptible humans and bats. |
|
Contact rate between susceptible humans and Ebola viruses. |
|
Contact rate between susceptible humans and infected animals. |
|
Contact rate between susceptible bats and infectious bats. |
|
Contact rate between susceptible animals and infectious bats. |
|
Contact rate between susceptible bats and and Ebola viruses. |
|
Contact rate between susceptible and infected animals. |
|
Contact rate between susceptible animals and Ebola viruses. |
Equilibria | Conditions of existence | Stability | |
| |
GAS | |
| |
GAS | |
| |
GAS | |
| |
GAS |
Parameters | | | | | |
| | 0.2343 | 0.1922 | 0.0124 | 0.0172 |
| -0.1822 | 0.2005 | 0.1610 | | 0.0180 |
| -0.3116 | | 0.3008 | | 0.0132 |
| | | | -0.0341 | 0.0329 |
| 0.1060 | -0.1786 | -0.1134 | | -0.0148 |
| | | | | |
| -0.0143 | -0.0493 | -0.0453 | -0.0530 | 0.0202 |
| 0.0030 | -0.0099 | 0.284 | -0.0491 | -0.0250 |
| -0.0107 | 0.0630 | 0.0010 | -0.1381 | 0.0356 |
| -0.0218 | 0.0572 | 0.0200 | -0.0509 | -0.0518 |
| -0.1213 | 0.1149 | 0.0410 | -0.1530 | 0.0256 |
| -0.1299 | -0.2465 | | 0.0513 | -0.0613 |
| 0.0463 | -0.0623 | 0.1735 | 0.0108 | 0.0092 |
| 0.0239 | -0.0450 | -0.0185 | -0.325 | -0.0044 |
| 0.0143 | 0.0490 | -0.0125 | 0.0067 | 0.0154 |
| 0.043 | 0.0177 | 0.1003 | -0.0653 | -0.0434 |
| 0.0078 | -0.0041 | -0.0254 | -0.0113 | -0.0506 |
| 0.0133 | 0.0073 | 0.0845 | -0.0410 | -0.0025 |
| 0.0142 | -0.0065 | | -0.0320 | -0.0106 |
| 0.0375 | -0.0581 | 0.0141 | 0.0003 | 0.0263 |
| -0.2682 | 0.3205 | 0.1217 | 0.0220 | 0.0038 |
| -0.3700 | | 0.3747 | -0.0114 | 0.0125 |
| 0.0785 | 0.0106 | 0.0022 | -0.0824 | -0.0129 |
| -0.1816 | 0.2399 | 0.1559 | -0.0395 | -0.0448 |
| 0.0196 | 0.0757 | 0.1389 | -0.0976 | |
| -0.0242 | 0.0984 | 0.0080 | | -0.0030 |
| -0.0214 | -0.0310 | -0.0280 | -0.0071 | 0.0391 |
| -0.0145 | 0.1266 | -0.0036 | | -0.0596 |
| -0.0214 | 0.0150 | 0.0718 | 0.0737 | 0.0339 |
Parameters | | | | |
| | 0.3341 | 0.0602 | 0.0406 |
| -0.1412 | 0.2206 | 0.8767 | -0.0122 |
| -0.3108 | | | -0.0214 |
| | | 0.0180 | 0.0341 |
| 0.0936 | -0.2108 | | -0.0046 |
| | | | |
| 0.0055 | 0.0391 | -0.0337 | -0.0270 |
| -0.0913 | 0.1327 | -0.0923 | -0.0041 |
| -0.0183 | 0.0184 | 0.0608 | -0.0183 |
| -0.0483 | 0.0745 | -0.0953 | -0.0253 |
| -0.1496 | -0.2233 | 0.0116 | 0.0046 |
| 0.0124 | -0.0410 | 0.0286 | -0.0295 |
| 0.0690 | -0.0647 | -0.3869 | 0.0175 |
| -0.0221 | 0.0308 | 0.0099 | 0.0539 |
| 0.0035 | -0.0057 | 0.0042 | 0.0170 |
| -0.2865 | 0.3144 | -0.0275 | -0.0105 |
| -0.3649 | | -0.0063 | -0.0131 |
| -0.2057 | 0.3168 | 0.0372 | 0.0050 |
| -0.0686 | 0.0757 | -0.2270 | |
| -0.0719 | 0.0684 | | -0.0245 |
| 0.0063 | 0.0049 | -0.2936 | 0.0053 |
Parameters | | | | |
| | 0.2046 | 0.1034 | 0.0202 |
| -0.3295 | | 0.3423 | -0.0096 |
| | | | 0.0203 |
| | | | |
| 0.01 | 0.0066 | 0.0254 | -0.0085 |
| -0.0047 | 0.0470 | 0.0421 | -0.0097 |
| -0.0110 | 0.0116 | -0.0052 | 0.0244 |
| -0.1750 | -0.1661 | | -0.0014 |
| 0.0404 | 0.0196 | 0.1127 | -0.0412 |
| -0.0375 | -0.0105 | 0.0071 | 0.0263 |
| 0.0091 | -0.0128 | -0.0147 | 0.0408 |
| -0.0182 | 0.0316 | 0.0038 | -0.0090 |
| 0.0037 | 0.0187 | | -0.0041 |
| -0.0096 | -0.0177 | 0.0319 | -0.0294 |
| -0.2646 | 0.3093 | 0.2130 | 0.0209 |
| -0.3794 | | | 0.0162 |
| 0.0055 | 0.0171 | -0.0102 | -0.0538 |
| -0.0803 | 0.0556 | 0.0875 | |
| -0.0094 | 0.0178 | -0.0178 | 0.0804 |
Parameters | Range | Values | Units | Source |
| Variable | 100 | | N/A |
| Variable | 5 | | N/A |
| Variable | 10 | | N/A |
| 0-1 | 0.33/365 | | [57] |
| 0-1 | 0.4/365 | | Assumed |
| 0-1 | 0.5/365 | | Assumed |
| 0-1 | 0.85/30 | | Assumed [10,46] |
| 0-1 | 1/2.5 | | [50,57] |
| 1-7 | 2.5 | | [50,57] |
| 0-1 | 1/7 | | Assumed |
| 1-14 | 7 | | Assumed |
| 1-5 | 1.2 | | Assumed |
| 1-5 | 1.3 | | Assumed |
| 1/2-1/21 | 1/21 | | [22,50] |
| 1/7-1/14 | 1/14 | | [57] |
| 0-1 | 0.5/365 | | Assumed |
| 10-100 | 50 | | [8] |
| 20-200 | 100 | | Assumed |
| 50-400 | 200 | | Assumed |
| 1/81-1 | 1/61 | | [50] |
| 1-81 | 61 | | [50] |
| 0.4-0.9 | 0.70 | dimensionless | [50,52,57] |
| | | [8] | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable | |
| 0-1 | | Variable |